ES2329085T3 - Derivados de (4-(benzo(b)tiofen-2-il)-pirimidin-2-il)-amina como inhibidores de ikk-beta para el tratamiento del cancer y de enfermedades inflamatorias. - Google Patents
Derivados de (4-(benzo(b)tiofen-2-il)-pirimidin-2-il)-amina como inhibidores de ikk-beta para el tratamiento del cancer y de enfermedades inflamatorias. Download PDFInfo
- Publication number
- ES2329085T3 ES2329085T3 ES06850430T ES06850430T ES2329085T3 ES 2329085 T3 ES2329085 T3 ES 2329085T3 ES 06850430 T ES06850430 T ES 06850430T ES 06850430 T ES06850430 T ES 06850430T ES 2329085 T3 ES2329085 T3 ES 2329085T3
- Authority
- ES
- Spain
- Prior art keywords
- benzo
- thiophene
- mmol
- carboxylic acid
- pyrimidin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010028980 Neoplasm Diseases 0.000 title claims description 17
- 201000011510 cancer Diseases 0.000 title claims description 17
- 208000027866 inflammatory disease Diseases 0.000 title description 7
- 239000003112 inhibitor Substances 0.000 title description 3
- 150000001875 compounds Chemical class 0.000 claims abstract description 336
- -1 methylthio, aminosulfonyl Chemical group 0.000 claims abstract description 200
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 88
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 48
- 150000003839 salts Chemical class 0.000 claims abstract description 47
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims abstract description 46
- 239000001257 hydrogen Substances 0.000 claims abstract description 44
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 44
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 30
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 150000002431 hydrogen Chemical class 0.000 claims abstract description 17
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 13
- 125000003386 piperidinyl group Chemical group 0.000 claims abstract description 13
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims abstract description 12
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 11
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 9
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims abstract description 8
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 6
- 125000002757 morpholinyl group Chemical group 0.000 claims abstract description 6
- 125000001424 substituent group Chemical group 0.000 claims abstract description 5
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 4
- 125000004193 piperazinyl group Chemical group 0.000 claims abstract description 4
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 claims abstract description 4
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims abstract description 4
- 125000004305 thiazinyl group Chemical group S1NC(=CC=C1)* 0.000 claims abstract description 4
- 101100240517 Caenorhabditis elegans nhr-11 gene Proteins 0.000 claims abstract description 3
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims abstract description 3
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 3
- 125000002883 imidazolyl group Chemical group 0.000 claims abstract description 3
- 125000006301 indolyl methyl group Chemical group 0.000 claims abstract description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 3
- 125000004076 pyridyl group Chemical group 0.000 claims abstract description 3
- 125000000335 thiazolyl group Chemical group 0.000 claims abstract description 3
- 125000004950 trifluoroalkyl group Chemical group 0.000 claims abstract description 3
- 125000001475 halogen functional group Chemical group 0.000 claims abstract 12
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract 8
- 239000002253 acid Substances 0.000 claims description 86
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims description 31
- MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 claims description 17
- ANCBHJKEYPZCTE-UHFFFAOYSA-N ethyl 5-carbamoyl-4-methyl-2-[(2,3,4,5,6-pentafluorobenzoyl)amino]thiophene-3-carboxylate Chemical compound CC1=C(C(N)=O)SC(NC(=O)C=2C(=C(F)C(F)=C(F)C=2F)F)=C1C(=O)OCC ANCBHJKEYPZCTE-UHFFFAOYSA-N 0.000 claims description 13
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 claims description 9
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 8
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims description 7
- 208000034578 Multiple myelomas Diseases 0.000 claims description 6
- 206010035226 Plasma cell myeloma Diseases 0.000 claims description 6
- 208000029742 colonic neoplasm Diseases 0.000 claims description 6
- 208000005017 glioblastoma Diseases 0.000 claims description 6
- 239000008194 pharmaceutical composition Substances 0.000 claims description 6
- 206010023774 Large cell lung cancer Diseases 0.000 claims description 5
- 206010033128 Ovarian cancer Diseases 0.000 claims description 5
- 201000009546 lung large cell carcinoma Diseases 0.000 claims description 5
- 206010061535 Ovarian neoplasm Diseases 0.000 claims description 4
- 239000003085 diluting agent Substances 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 208000029565 malignant colon neoplasm Diseases 0.000 claims 1
- 125000004399 C1-C4 alkenyl group Chemical group 0.000 abstract description 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 713
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 394
- 239000007787 solid Substances 0.000 description 315
- 239000000203 mixture Substances 0.000 description 262
- 239000000243 solution Substances 0.000 description 198
- 238000000034 method Methods 0.000 description 160
- 238000002360 preparation method Methods 0.000 description 156
- 239000000460 chlorine Substances 0.000 description 146
- 239000012458 free base Substances 0.000 description 119
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 107
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 98
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 92
- 239000000725 suspension Substances 0.000 description 92
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 78
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 74
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 73
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 71
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 70
- 239000003921 oil Substances 0.000 description 65
- 239000000741 silica gel Substances 0.000 description 58
- 229910002027 silica gel Inorganic materials 0.000 description 58
- 238000006243 chemical reaction Methods 0.000 description 55
- 238000003756 stirring Methods 0.000 description 52
- 238000010898 silica gel chromatography Methods 0.000 description 51
- 235000019439 ethyl acetate Nutrition 0.000 description 43
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 42
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 41
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 41
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 38
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 37
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 35
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 34
- 239000012044 organic layer Substances 0.000 description 33
- 239000000047 product Substances 0.000 description 33
- 239000011541 reaction mixture Substances 0.000 description 33
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 32
- 150000002148 esters Chemical class 0.000 description 32
- 238000001914 filtration Methods 0.000 description 32
- HWDVTQAXQJQROO-UHFFFAOYSA-N cyclopropylazanide Chemical compound [NH-]C1CC1 HWDVTQAXQJQROO-UHFFFAOYSA-N 0.000 description 30
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 30
- 230000002829 reductive effect Effects 0.000 description 29
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 28
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 25
- 238000004587 chromatography analysis Methods 0.000 description 25
- 238000000746 purification Methods 0.000 description 25
- 239000012043 crude product Substances 0.000 description 24
- AQRLNPVMDITEJU-UHFFFAOYSA-N triethylsilane Chemical compound CC[SiH](CC)CC AQRLNPVMDITEJU-UHFFFAOYSA-N 0.000 description 24
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 23
- 210000004027 cell Anatomy 0.000 description 22
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 21
- 238000001035 drying Methods 0.000 description 21
- 230000008569 process Effects 0.000 description 21
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 19
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 18
- RGUABPVONIGVAT-UHFFFAOYSA-N 3-(4-methylpiperazin-1-yl)propan-1-amine Chemical compound CN1CCN(CCCN)CC1 RGUABPVONIGVAT-UHFFFAOYSA-N 0.000 description 17
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 17
- 239000007789 gas Substances 0.000 description 17
- 239000012299 nitrogen atmosphere Substances 0.000 description 17
- YNVOMSDITJMNET-UHFFFAOYSA-N thiophene-3-carboxylic acid Chemical compound OC(=O)C=1C=CSC=1 YNVOMSDITJMNET-UHFFFAOYSA-N 0.000 description 17
- 239000002904 solvent Substances 0.000 description 16
- 239000012258 stirred mixture Substances 0.000 description 16
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- KLBAONGYSCOBHX-UHFFFAOYSA-N 2-[5-chloro-2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-1-benzothiophene-4-carboxylic acid Chemical compound C1CN(C)CCN1CCCNC1=NC=C(Cl)C(C=2SC3=CC=CC(=C3C=2)C(O)=O)=N1 KLBAONGYSCOBHX-UHFFFAOYSA-N 0.000 description 14
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 14
- 241000124008 Mammalia Species 0.000 description 14
- 239000000706 filtrate Substances 0.000 description 14
- 239000013067 intermediate product Substances 0.000 description 14
- GSQDFHSGLFZEMW-UHFFFAOYSA-N n-cyclopropyl-2-(2,5-dichloropyrimidin-4-yl)-1-benzothiophene-4-carboxamide Chemical compound ClC1=NC=C(Cl)C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)=N1 GSQDFHSGLFZEMW-UHFFFAOYSA-N 0.000 description 14
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 14
- 238000010992 reflux Methods 0.000 description 14
- 239000011780 sodium chloride Substances 0.000 description 14
- ODQTWTGPDQOEFJ-UHFFFAOYSA-N 2-(2,5-dichloropyrimidin-4-yl)-1-benzothiophene-4-carboxylic acid Chemical compound C=1C=2C(C(=O)O)=CC=CC=2SC=1C1=NC(Cl)=NC=C1Cl ODQTWTGPDQOEFJ-UHFFFAOYSA-N 0.000 description 13
- 239000010410 layer Substances 0.000 description 13
- NHDIQVFFNDKAQU-UHFFFAOYSA-N tripropan-2-yl borate Chemical compound CC(C)OB(OC(C)C)OC(C)C NHDIQVFFNDKAQU-UHFFFAOYSA-N 0.000 description 13
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 12
- OQIMJOXSDVGEBU-UHFFFAOYSA-N 6-bromo-1-benzothiophene Chemical compound BrC1=CC=C2C=CSC2=C1 OQIMJOXSDVGEBU-UHFFFAOYSA-N 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 12
- 238000001816 cooling Methods 0.000 description 12
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 12
- 229920006395 saturated elastomer Polymers 0.000 description 12
- CGVKBSGIGZOHFS-UHFFFAOYSA-N 2-[5-chloro-2-[2-(1-methylpiperidin-4-yl)ethylamino]pyrimidin-4-yl]-1-benzothiophene-4-carboxamide;dihydrochloride Chemical compound Cl.Cl.C1CN(C)CCC1CCNC1=NC=C(Cl)C(C=2SC3=CC=CC(=C3C=2)C(N)=O)=N1 CGVKBSGIGZOHFS-UHFFFAOYSA-N 0.000 description 11
- STNOBDOQYMUVEB-UHFFFAOYSA-N 4-(1-benzothiophen-2-yl)-n-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine Chemical compound C1CN(C)CCN1CCCNC1=NC=CC(C=2SC3=CC=CC=C3C=2)=N1 STNOBDOQYMUVEB-UHFFFAOYSA-N 0.000 description 11
- 239000006260 foam Substances 0.000 description 11
- 239000012071 phase Substances 0.000 description 11
- 230000002441 reversible effect Effects 0.000 description 11
- 229910000029 sodium carbonate Inorganic materials 0.000 description 11
- 235000017550 sodium carbonate Nutrition 0.000 description 11
- OPQRMLFPDZPBKA-UHFFFAOYSA-N 2-(5-bromo-2-chloropyrimidin-4-yl)-n-cyclopropyl-1-benzothiophene-4-carboxamide Chemical compound ClC1=NC=C(Br)C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)=N1 OPQRMLFPDZPBKA-UHFFFAOYSA-N 0.000 description 10
- 102000001284 I-kappa-B kinase Human genes 0.000 description 10
- 108060006678 I-kappa-B kinase Proteins 0.000 description 10
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
- 150000001412 amines Chemical class 0.000 description 10
- 238000011097 chromatography purification Methods 0.000 description 10
- 239000013058 crude material Substances 0.000 description 10
- 125000005843 halogen group Chemical group 0.000 description 10
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 10
- 235000019341 magnesium sulphate Nutrition 0.000 description 10
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 9
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 229910002091 carbon monoxide Inorganic materials 0.000 description 9
- KFVFPOGBNARWQS-UHFFFAOYSA-N n-cyclopropyl-2-[5-fluoro-2-(3-piperidin-4-ylpropylamino)pyrimidin-4-yl]-1-benzothiophene-4-carboxamide Chemical compound N1=C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)C(F)=CN=C1NCCCC1CCNCC1 KFVFPOGBNARWQS-UHFFFAOYSA-N 0.000 description 9
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 8
- IZXMGGLFJGYNBW-UHFFFAOYSA-N 3-(4-propan-2-ylpiperazin-1-yl)propan-1-amine Chemical compound CC(C)N1CCN(CCCN)CC1 IZXMGGLFJGYNBW-UHFFFAOYSA-N 0.000 description 8
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 8
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 8
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- 239000012141 concentrate Substances 0.000 description 8
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 8
- 239000012279 sodium borohydride Substances 0.000 description 8
- 229910000033 sodium borohydride Inorganic materials 0.000 description 8
- 229910052938 sodium sulfate Inorganic materials 0.000 description 8
- 235000011152 sodium sulphate Nutrition 0.000 description 8
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 7
- GIKMWFAAEIACRF-UHFFFAOYSA-N 2,4,5-trichloropyrimidine Chemical compound ClC1=NC=C(Cl)C(Cl)=N1 GIKMWFAAEIACRF-UHFFFAOYSA-N 0.000 description 7
- XSGXZJPLDGFVCT-UHFFFAOYSA-N 2-(2-chloro-5-methylpyrimidin-4-yl)-n-cyclopropyl-1-benzothiophene-4-carboxamide Chemical compound CC1=CN=C(Cl)N=C1C1=CC2=C(C(=O)NC3CC3)C=CC=C2S1 XSGXZJPLDGFVCT-UHFFFAOYSA-N 0.000 description 7
- HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 description 7
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 7
- 239000007832 Na2SO4 Substances 0.000 description 7
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 description 6
- BTTNYQZNBZNDOR-UHFFFAOYSA-N 2,4-dichloropyrimidine Chemical compound ClC1=CC=NC(Cl)=N1 BTTNYQZNBZNDOR-UHFFFAOYSA-N 0.000 description 6
- ORVKQCGPESOXOL-UHFFFAOYSA-N 4-[6-(aminomethyl)-1-benzothiophen-2-yl]-5-chloro-n-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine Chemical compound C1CN(C)CCN1CCCNC1=NC=C(Cl)C(C=2SC3=CC(CN)=CC=C3C=2)=N1 ORVKQCGPESOXOL-UHFFFAOYSA-N 0.000 description 6
- RWWDZFRDYYQTFJ-UHFFFAOYSA-N 7-methoxy-1-benzothiophene Chemical compound COC1=CC=CC2=C1SC=C2 RWWDZFRDYYQTFJ-UHFFFAOYSA-N 0.000 description 6
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 238000010511 deprotection reaction Methods 0.000 description 6
- 229940043279 diisopropylamine Drugs 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000012091 fetal bovine serum Substances 0.000 description 6
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 6
- 238000000527 sonication Methods 0.000 description 6
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 6
- FQFILJKFZCVHNH-UHFFFAOYSA-N tert-butyl n-[3-[(5-bromo-2-chloropyrimidin-4-yl)amino]propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCNC1=NC(Cl)=NC=C1Br FQFILJKFZCVHNH-UHFFFAOYSA-N 0.000 description 6
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 6
- 238000002604 ultrasonography Methods 0.000 description 6
- CXNIUSPIQKWYAI-UHFFFAOYSA-N xantphos Chemical compound C=12OC3=C(P(C=4C=CC=CC=4)C=4C=CC=CC=4)C=CC=C3C(C)(C)C2=CC=CC=1P(C=1C=CC=CC=1)C1=CC=CC=C1 CXNIUSPIQKWYAI-UHFFFAOYSA-N 0.000 description 6
- 125000004484 1-methylpiperidin-4-yl group Chemical group CN1CCC(CC1)* 0.000 description 5
- DQXNTSXKIUZJJS-UHFFFAOYSA-N 2,4-dichloro-5-methylpyrimidine Chemical compound CC1=CN=C(Cl)N=C1Cl DQXNTSXKIUZJJS-UHFFFAOYSA-N 0.000 description 5
- NJNBYFGZXZBXEJ-UHFFFAOYSA-N 2-(2,5-dichloropyrimidin-4-yl)-7-methoxy-1-benzothiophene-4-carboxylic acid Chemical compound S1C=2C(OC)=CC=C(C(O)=O)C=2C=C1C1=NC(Cl)=NC=C1Cl NJNBYFGZXZBXEJ-UHFFFAOYSA-N 0.000 description 5
- DTAJKPICAHMNKN-UHFFFAOYSA-N 2-(2-chloro-5-fluoropyrimidin-4-yl)-n-cyclopropyl-1-benzothiophene-4-carboxamide Chemical compound FC1=CN=C(Cl)N=C1C1=CC2=C(C(=O)NC3CC3)C=CC=C2S1 DTAJKPICAHMNKN-UHFFFAOYSA-N 0.000 description 5
- BLAKMOKDSBCFQA-UHFFFAOYSA-N 2-[5-chloro-2-(3-piperazin-1-ylpropylamino)pyrimidin-4-yl]-n-cyclopropyl-1-benzothiophene-4-carboxamide Chemical compound N1=C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)C(Cl)=CN=C1NCCCN1CCNCC1 BLAKMOKDSBCFQA-UHFFFAOYSA-N 0.000 description 5
- SHKGXHKLGJPRFV-UHFFFAOYSA-N 2-[5-methyl-2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-1-benzothiophene-6-carboxylic acid Chemical compound C1CN(C)CCN1CCCNC1=NC=C(C)C(C=2SC3=CC(=CC=C3C=2)C(O)=O)=N1 SHKGXHKLGJPRFV-UHFFFAOYSA-N 0.000 description 5
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 5
- BANCBYXNLZNSCC-UHFFFAOYSA-N 4-(1-benzothiophen-2-yl)-2-chloropyrimidine Chemical compound ClC1=NC=CC(C=2SC3=CC=CC=C3C=2)=N1 BANCBYXNLZNSCC-UHFFFAOYSA-N 0.000 description 5
- CZYLLBIIVPBDLL-UHFFFAOYSA-N 4-(3-aminopropyl)piperidine-1-carboxylic acid Chemical compound NCCCC1CCN(C(O)=O)CC1 CZYLLBIIVPBDLL-UHFFFAOYSA-N 0.000 description 5
- BCJVBDBJSMFBRW-UHFFFAOYSA-N 4-diphenylphosphanylbutyl(diphenyl)phosphane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)CCCCP(C=1C=CC=CC=1)C1=CC=CC=C1 BCJVBDBJSMFBRW-UHFFFAOYSA-N 0.000 description 5
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 5
- 206010009944 Colon cancer Diseases 0.000 description 5
- 108091000080 Phosphotransferase Proteins 0.000 description 5
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 5
- 229910052794 bromium Inorganic materials 0.000 description 5
- QJBXPIZGUYIVKB-UHFFFAOYSA-N cyclopropanamine;dihydrochloride Chemical compound Cl.Cl.NC1CC1 QJBXPIZGUYIVKB-UHFFFAOYSA-N 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 5
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 5
- 102000020233 phosphotransferase Human genes 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- 239000000377 silicon dioxide Substances 0.000 description 5
- REVHWEJAHDLSTJ-UHFFFAOYSA-N 1-benzothiophene-4-carboxylic acid Chemical compound OC(=O)C1=CC=CC2=C1C=CS2 REVHWEJAHDLSTJ-UHFFFAOYSA-N 0.000 description 4
- 125000004486 1-methylpiperidin-3-yl group Chemical group CN1CC(CCC1)* 0.000 description 4
- ORKBXFPBEZOEAF-UHFFFAOYSA-N 2-(2-chloro-5-fluoropyrimidin-4-yl)-1-benzothiophene-4-carboxylic acid Chemical compound C=1C=2C(C(=O)O)=CC=CC=2SC=1C1=NC(Cl)=NC=C1F ORKBXFPBEZOEAF-UHFFFAOYSA-N 0.000 description 4
- SEVMKSHOLBWASC-UHFFFAOYSA-N 2-(2-chloro-5-methylpyrimidin-4-yl)-n-methyl-1-benzothiophene-4-carboxamide Chemical compound C=1C=2C(C(=O)NC)=CC=CC=2SC=1C1=NC(Cl)=NC=C1C SEVMKSHOLBWASC-UHFFFAOYSA-N 0.000 description 4
- WXMOCNDNEIHEDR-UHFFFAOYSA-N 2-(5-bromo-2-chloropyrimidin-4-yl)-n-methyl-1-benzothiophene-4-carboxamide Chemical compound C=1C=2C(C(=O)NC)=CC=CC=2SC=1C1=NC(Cl)=NC=C1Br WXMOCNDNEIHEDR-UHFFFAOYSA-N 0.000 description 4
- BKCQWQXYCXYEJI-UHFFFAOYSA-N 2-[5-chloro-2-[2-(1-methylpiperidin-4-yl)ethylamino]pyrimidin-4-yl]-n-cyclopropyl-1-benzothiophene-4-carboxamide;dihydrochloride Chemical compound Cl.Cl.C1CN(C)CCC1CCNC1=NC=C(Cl)C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)=N1 BKCQWQXYCXYEJI-UHFFFAOYSA-N 0.000 description 4
- FNQMFCIMKRTQOG-UHFFFAOYSA-N 2-[5-chloro-2-[3-(4-ethylpiperidin-4-yl)propylamino]pyrimidin-4-yl]-n-cyclopropyl-1-benzothiophene-4-carboxamide;dihydrochloride Chemical compound Cl.Cl.N=1C=C(Cl)C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)=NC=1NCCCC1(CC)CCNCC1 FNQMFCIMKRTQOG-UHFFFAOYSA-N 0.000 description 4
- CVMKBMWKWYXTRH-UHFFFAOYSA-N 3-piperidin-4-ylpropan-1-amine Chemical compound NCCCC1CCNCC1 CVMKBMWKWYXTRH-UHFFFAOYSA-N 0.000 description 4
- GEFRPLQHEVUGNR-UHFFFAOYSA-N 4-(1-benzothiophen-2-yl)-5-chloro-n-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine Chemical compound C1CN(C)CCN1CCCNC1=NC=C(Cl)C(C=2SC3=CC=CC=C3C=2)=N1 GEFRPLQHEVUGNR-UHFFFAOYSA-N 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- 229910002666 PdCl2 Inorganic materials 0.000 description 4
- 102000001253 Protein Kinase Human genes 0.000 description 4
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- 102100040247 Tumor necrosis factor Human genes 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 150000001408 amides Chemical class 0.000 description 4
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 4
- YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
- 229960001701 chloroform Drugs 0.000 description 4
- 238000006073 displacement reaction Methods 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 230000002757 inflammatory effect Effects 0.000 description 4
- 239000011630 iodine Substances 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- OVEHNNQXLPJPPL-UHFFFAOYSA-N lithium;n-propan-2-ylpropan-2-amine Chemical compound [Li].CC(C)NC(C)C OVEHNNQXLPJPPL-UHFFFAOYSA-N 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 4
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 150000003141 primary amines Chemical class 0.000 description 4
- 125000006308 propyl amino group Chemical group 0.000 description 4
- 125000006239 protecting group Chemical group 0.000 description 4
- 108060006633 protein kinase Proteins 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 4
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- QZYIDMYWRACBRQ-UHFFFAOYSA-N tert-butyl 4-(3-aminopropyl)piperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(CCCN)CC1 QZYIDMYWRACBRQ-UHFFFAOYSA-N 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- PDQRQJVPEFGVRK-UHFFFAOYSA-N 2,1,3-benzothiadiazole Chemical compound C1=CC=CC2=NSN=C21 PDQRQJVPEFGVRK-UHFFFAOYSA-N 0.000 description 3
- UGDUZSBWKUJBNP-UHFFFAOYSA-N 2,5-dichloro-4-(6-methylsulfanyl-1-benzothiophen-2-yl)pyrimidine Chemical compound S1C2=CC(SC)=CC=C2C=C1C1=NC(Cl)=NC=C1Cl UGDUZSBWKUJBNP-UHFFFAOYSA-N 0.000 description 3
- GHQHDNVJWUGWEQ-UHFFFAOYSA-N 2-(2,2,6,6-tetramethylpiperidin-4-ylidene)ethanamine Chemical compound CC1(C)CC(=CCN)CC(C)(C)N1 GHQHDNVJWUGWEQ-UHFFFAOYSA-N 0.000 description 3
- RASHJDBCDWOILU-UHFFFAOYSA-N 2-(2,5-dichloropyrimidin-4-yl)-1-benzothiophene-4-carboxamide Chemical compound C=1C=2C(C(=O)N)=CC=CC=2SC=1C1=NC(Cl)=NC=C1Cl RASHJDBCDWOILU-UHFFFAOYSA-N 0.000 description 3
- VLNGTGPAHWKGHA-UHFFFAOYSA-N 2-(2,5-dichloropyrimidin-4-yl)-n-methyl-1-benzothiophene-4-carboxamide Chemical compound C=1C=2C(C(=O)NC)=CC=CC=2SC=1C1=NC(Cl)=NC=C1Cl VLNGTGPAHWKGHA-UHFFFAOYSA-N 0.000 description 3
- JFBNLELOIYRXCM-UHFFFAOYSA-N 2-(2-chloro-5-methylpyrimidin-4-yl)-1-benzothiophene-4-carboxylic acid Chemical compound CC1=CN=C(Cl)N=C1C1=CC2=C(C(O)=O)C=CC=C2S1 JFBNLELOIYRXCM-UHFFFAOYSA-N 0.000 description 3
- WFDYRXGNPSKVBE-UHFFFAOYSA-N 2-(2-chloro-5-methylpyrimidin-4-yl)-n-methyl-1-benzothiophene-6-carboxamide Chemical compound S1C2=CC(C(=O)NC)=CC=C2C=C1C1=NC(Cl)=NC=C1C WFDYRXGNPSKVBE-UHFFFAOYSA-N 0.000 description 3
- VKJCJJYNVIYVQR-UHFFFAOYSA-N 2-(3-bromopropyl)isoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(CCCBr)C(=O)C2=C1 VKJCJJYNVIYVQR-UHFFFAOYSA-N 0.000 description 3
- UGFLQQKYWNQFFT-UHFFFAOYSA-N 2-(5-bromo-2-chloropyrimidin-4-yl)-1-benzothiophene-4-carboxylic acid Chemical compound C=1C=2C(C(=O)O)=CC=CC=2SC=1C1=NC(Cl)=NC=C1Br UGFLQQKYWNQFFT-UHFFFAOYSA-N 0.000 description 3
- OYCFZVQUJYOJRE-UHFFFAOYSA-N 2-[5-bromo-2-(2-piperidin-4-ylethylamino)pyrimidin-4-yl]-n-cyclopropyl-1-benzothiophene-4-carboxamide Chemical compound N1=C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)C(Br)=CN=C1NCCC1CCNCC1 OYCFZVQUJYOJRE-UHFFFAOYSA-N 0.000 description 3
- DHFAXRJULKQITI-UHFFFAOYSA-N 2-[5-chloro-2-[2-(1-ethylpiperidin-4-yl)ethylamino]pyrimidin-4-yl]-n-cyclopropyl-1-benzothiophene-4-carboxamide;dihydrochloride Chemical compound Cl.Cl.C1CN(CC)CCC1CCNC1=NC=C(Cl)C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)=N1 DHFAXRJULKQITI-UHFFFAOYSA-N 0.000 description 3
- LTVVRNJQGCKLJL-UHFFFAOYSA-N 2-[5-chloro-2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-1-benzothiophene-6-carboxylic acid Chemical compound C1CN(C)CCN1CCCNC1=NC=C(Cl)C(C=2SC3=CC(=CC=C3C=2)C(O)=O)=N1 LTVVRNJQGCKLJL-UHFFFAOYSA-N 0.000 description 3
- VMUFNTKYYQNRKK-UHFFFAOYSA-N 2-borono-1-benzothiophene-4-carboxylic acid Chemical compound C1=CC=C2SC(B(O)O)=CC2=C1C(O)=O VMUFNTKYYQNRKK-UHFFFAOYSA-N 0.000 description 3
- VRSWRZBNEHRBSL-UHFFFAOYSA-N 3-(4-methyl-1,4-diazepan-1-yl)propan-1-amine Chemical compound CN1CCCN(CCCN)CC1 VRSWRZBNEHRBSL-UHFFFAOYSA-N 0.000 description 3
- BSCYXQIPEYZODK-UHFFFAOYSA-N 3-(diethylamino)propyl-(ethyliminomethylidene)azanium;chloride Chemical compound Cl.CCN=C=NCCCN(CC)CC BSCYXQIPEYZODK-UHFFFAOYSA-N 0.000 description 3
- QZVQQUVWFIZUBQ-UHFFFAOYSA-N 3-fluoroaniline Chemical compound NC1=CC=CC(F)=C1 QZVQQUVWFIZUBQ-UHFFFAOYSA-N 0.000 description 3
- WHANFJKAMIVWOD-UHFFFAOYSA-N 4-(1-benzothiophen-2-yl)-5-bromo-2-chloropyrimidine Chemical compound ClC1=NC=C(Br)C(C=2SC3=CC=CC=C3C=2)=N1 WHANFJKAMIVWOD-UHFFFAOYSA-N 0.000 description 3
- FIVOUGQSAJBFJR-UHFFFAOYSA-N 4-(3-aminopropyl)piperazine-1-carboxylic acid Chemical compound NCCCN1CCN(C(O)=O)CC1 FIVOUGQSAJBFJR-UHFFFAOYSA-N 0.000 description 3
- CHQOOTQWZWLCRA-UHFFFAOYSA-N 4-(6-amino-1-benzothiophen-2-yl)-5-methyl-n-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine Chemical compound C1CN(C)CCN1CCCNC1=NC=C(C)C(C=2SC3=CC(N)=CC=C3C=2)=N1 CHQOOTQWZWLCRA-UHFFFAOYSA-N 0.000 description 3
- ZELCMVLXDKQJJM-UHFFFAOYSA-N 4-(6-bromo-1-benzothiophen-2-yl)-2,5-dichloropyrimidine Chemical compound ClC1=NC=C(Cl)C(C=2SC3=CC(Br)=CC=C3C=2)=N1 ZELCMVLXDKQJJM-UHFFFAOYSA-N 0.000 description 3
- JSMCIROGTPUSCX-UHFFFAOYSA-N 4-(6-bromo-1-benzothiophen-2-yl)-n-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine Chemical compound C1CN(C)CCN1CCCNC1=NC=CC(C=2SC3=CC(Br)=CC=C3C=2)=N1 JSMCIROGTPUSCX-UHFFFAOYSA-N 0.000 description 3
- UEWGLFRGAFMFSI-UHFFFAOYSA-N 4-(7-chloro-1-benzothiophen-2-yl)-n-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine Chemical compound C1CN(C)CCN1CCCNC1=NC=CC(C=2SC3=C(Cl)C=CC=C3C=2)=N1 UEWGLFRGAFMFSI-UHFFFAOYSA-N 0.000 description 3
- QPBSEYFVZDMBFW-UHFFFAOYSA-N 4-bromo-1-benzothiophene Chemical compound BrC1=CC=CC2=C1C=CS2 QPBSEYFVZDMBFW-UHFFFAOYSA-N 0.000 description 3
- UTVIGGSAYUBRIP-UHFFFAOYSA-N 5-chloro-4-(7-methoxy-1-benzothiophen-2-yl)-n-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine Chemical compound S1C=2C(OC)=CC=CC=2C=C1C(C(=CN=1)Cl)=NC=1NCCCN1CCN(C)CC1 UTVIGGSAYUBRIP-UHFFFAOYSA-N 0.000 description 3
- GKWIITWUDNYXMG-UHFFFAOYSA-N 7-chloro-1-benzothiophene Chemical compound ClC1=CC=CC2=C1SC=C2 GKWIITWUDNYXMG-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- RPVJJYPABDILGQ-UHFFFAOYSA-N NCCCC1CN(CCC1)C(=O)O Chemical compound NCCCC1CN(CCC1)C(=O)O RPVJJYPABDILGQ-UHFFFAOYSA-N 0.000 description 3
- WZAJQLXZNKZWFK-QMMMGPOBSA-N NCCCN1[C@H](CN(CC1)C(=O)O)C Chemical compound NCCCN1[C@H](CN(CC1)C(=O)O)C WZAJQLXZNKZWFK-QMMMGPOBSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 239000012980 RPMI-1640 medium Substances 0.000 description 3
- ASLVBVFVJJFKDB-UHFFFAOYSA-N [2-[5-chloro-2-(3-piperazin-1-ylpropylamino)pyrimidin-4-yl]-1-benzothiophen-6-yl]-morpholin-4-ylmethanone Chemical compound N1=C(C=2SC3=CC(=CC=C3C=2)C(=O)N2CCOCC2)C(Cl)=CN=C1NCCCN1CCNCC1 ASLVBVFVJJFKDB-UHFFFAOYSA-N 0.000 description 3
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 3
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 3
- 229910000024 caesium carbonate Inorganic materials 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- KHXGPSURRKQMGG-UHFFFAOYSA-N n-[bis(4-methoxyphenyl)methyl]-2-(2-chloro-5-methylpyrimidin-4-yl)-1-benzothiophene-4-carboxamide Chemical compound C1=CC(OC)=CC=C1C(C=1C=CC(OC)=CC=1)NC(=O)C1=CC=CC2=C1C=C(C=1C(=CN=C(Cl)N=1)C)S2 KHXGPSURRKQMGG-UHFFFAOYSA-N 0.000 description 3
- QCMIOIYZLLUDSG-UHFFFAOYSA-N n-cyclopropyl-2-(2,5-dichloropyrimidin-4-yl)-7-methoxy-1-benzothiophene-4-carboxamide Chemical compound C1=2C=C(C=3C(=CN=C(Cl)N=3)Cl)SC=2C(OC)=CC=C1C(=O)NC1CC1 QCMIOIYZLLUDSG-UHFFFAOYSA-N 0.000 description 3
- KCLUCLMGYJOLAL-UHFFFAOYSA-N n-cyclopropyl-2-[5-fluoro-2-[3-(1-methylpiperidin-4-yl)propylamino]pyrimidin-4-yl]-1-benzothiophene-4-carboxamide;dihydrochloride Chemical compound Cl.Cl.C1CN(C)CCC1CCCNC1=NC=C(F)C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)=N1 KCLUCLMGYJOLAL-UHFFFAOYSA-N 0.000 description 3
- WSDLNICGQJGNCC-UHFFFAOYSA-N n-cyclopropyl-2-[5-methyl-2-(2-piperidin-4-ylethylamino)pyrimidin-4-yl]-1-benzothiophene-4-carboxamide Chemical compound N1=C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)C(C)=CN=C1NCCC1CCNCC1 WSDLNICGQJGNCC-UHFFFAOYSA-N 0.000 description 3
- JGHNGVXNZSFPNB-UHFFFAOYSA-N n-cyclopropyl-2-[5-methyl-2-[2-(1-methylpiperidin-4-yl)ethylamino]pyrimidin-4-yl]-1-benzothiophene-4-carboxamide;dihydrochloride Chemical compound Cl.Cl.C1CN(C)CCC1CCNC1=NC=C(C)C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)=N1 JGHNGVXNZSFPNB-UHFFFAOYSA-N 0.000 description 3
- BIZQEZVVSZIBHW-UHFFFAOYSA-N n-cyclopropyl-2-[5-methyl-2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-1-benzothiophene-4-carboxamide;dihydrochloride Chemical compound Cl.Cl.C1CN(C)CCN1CCCNC1=NC=C(C)C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)=N1 BIZQEZVVSZIBHW-UHFFFAOYSA-N 0.000 description 3
- 229910052763 palladium Inorganic materials 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- DQTITUCBHJBIDC-UHFFFAOYSA-N tert-butyl 4-(3-aminopropyl)-4-ethylpiperidine-1-carboxylate Chemical compound NCCCC1(CC)CCN(C(=O)OC(C)(C)C)CC1 DQTITUCBHJBIDC-UHFFFAOYSA-N 0.000 description 3
- DQLCYLFCLQPLSY-UHFFFAOYSA-N tert-butyl 4-(3-aminopropyl)piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCN(CCCN)CC1 DQLCYLFCLQPLSY-UHFFFAOYSA-N 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- XINQFOMFQFGGCQ-UHFFFAOYSA-L (2-dodecoxy-2-oxoethyl)-[6-[(2-dodecoxy-2-oxoethyl)-dimethylazaniumyl]hexyl]-dimethylazanium;dichloride Chemical compound [Cl-].[Cl-].CCCCCCCCCCCCOC(=O)C[N+](C)(C)CCCCCC[N+](C)(C)CC(=O)OCCCCCCCCCCCC XINQFOMFQFGGCQ-UHFFFAOYSA-L 0.000 description 2
- IFNWESYYDINUHV-OLQVQODUSA-N (2s,6r)-2,6-dimethylpiperazine Chemical compound C[C@H]1CNC[C@@H](C)N1 IFNWESYYDINUHV-OLQVQODUSA-N 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- WMKGGPCROCCUDY-UHFFFAOYSA-N 1,5-diphenylpenta-1,4-dien-3-one Chemical compound C=1C=CC=CC=1C=CC(=O)C=CC1=CC=CC=C1 WMKGGPCROCCUDY-UHFFFAOYSA-N 0.000 description 2
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 2
- BMRZGYNNZTVECK-UHFFFAOYSA-N 1-benzothiophen-4-ol Chemical compound OC1=CC=CC2=C1C=CS2 BMRZGYNNZTVECK-UHFFFAOYSA-N 0.000 description 2
- GVIJCJVCCVLVHW-UHFFFAOYSA-N 1-benzothiophen-4-yloxy-tert-butyl-dimethylsilane Chemical compound CC(C)(C)[Si](C)(C)OC1=CC=CC2=C1C=CS2 GVIJCJVCCVLVHW-UHFFFAOYSA-N 0.000 description 2
- CHKYKCBEIFLRRR-UHFFFAOYSA-N 1-benzothiophen-6-amine Chemical compound NC1=CC=C2C=CSC2=C1 CHKYKCBEIFLRRR-UHFFFAOYSA-N 0.000 description 2
- GRNONARPFXAEBM-UHFFFAOYSA-N 1-benzothiophene-6-carbonitrile Chemical compound N#CC1=CC=C2C=CSC2=C1 GRNONARPFXAEBM-UHFFFAOYSA-N 0.000 description 2
- UBGLFJRIBBEOPZ-UHFFFAOYSA-N 2,5-dichloro-4-(7-methoxy-1-benzothiophen-2-yl)pyrimidine Chemical compound S1C=2C(OC)=CC=CC=2C=C1C1=NC(Cl)=NC=C1Cl UBGLFJRIBBEOPZ-UHFFFAOYSA-N 0.000 description 2
- GPNZVRMSFKCBAR-UHFFFAOYSA-N 2-(2,5-dichloropyrimidin-4-yl)-1-benzothiophene-6-carbonitrile Chemical compound ClC1=NC=C(Cl)C(C=2SC3=CC(=CC=C3C=2)C#N)=N1 GPNZVRMSFKCBAR-UHFFFAOYSA-N 0.000 description 2
- AVDAZAOAFMQRAV-UHFFFAOYSA-N 2-(2,5-dichloropyrimidin-4-yl)-n-methyl-1-benzothiophene-6-carboxamide Chemical compound S1C2=CC(C(=O)NC)=CC=C2C=C1C1=NC(Cl)=NC=C1Cl AVDAZAOAFMQRAV-UHFFFAOYSA-N 0.000 description 2
- SCBQZPXBTYCARL-UHFFFAOYSA-N 2-(2-aminoethyl)piperidine-1-carboxylic acid Chemical compound NCCC1CCCCN1C(O)=O SCBQZPXBTYCARL-UHFFFAOYSA-N 0.000 description 2
- XOAGSFDDXRLSFM-UHFFFAOYSA-N 2-(2-chloro-5-methylpyrimidin-4-yl)-1-benzothiophen-4-ol Chemical compound CC1=CN=C(Cl)N=C1C1=CC2=C(O)C=CC=C2S1 XOAGSFDDXRLSFM-UHFFFAOYSA-N 0.000 description 2
- DPJQBUJVEKATNY-UHFFFAOYSA-N 2-(2-chloro-5-methylpyrimidin-4-yl)-n,n-dimethyl-1-benzothiophene-6-carboxamide Chemical compound S1C2=CC(C(=O)N(C)C)=CC=C2C=C1C1=NC(Cl)=NC=C1C DPJQBUJVEKATNY-UHFFFAOYSA-N 0.000 description 2
- BIWRUUACXPFKGN-UHFFFAOYSA-N 2-(2-chloropyrimidin-4-yl)-1-benzothiophene-4-carboxamide Chemical compound C=1C=2C(C(=O)N)=CC=CC=2SC=1C1=CC=NC(Cl)=N1 BIWRUUACXPFKGN-UHFFFAOYSA-N 0.000 description 2
- BHEGEJJOAIOEOQ-UHFFFAOYSA-N 2-[2-(3-aminopropylamino)-5-chloropyrimidin-4-yl]-n-cyclopropyl-1-benzothiophene-4-carboxamide Chemical compound NCCCNC1=NC=C(Cl)C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)=N1 BHEGEJJOAIOEOQ-UHFFFAOYSA-N 0.000 description 2
- QFRXYVHBUZCNBB-UHFFFAOYSA-N 2-[3-(4-propan-2-ylpiperazin-1-yl)propyl]isoindole-1,3-dione Chemical compound C1CN(C(C)C)CCN1CCCN1C(=O)C2=CC=CC=C2C1=O QFRXYVHBUZCNBB-UHFFFAOYSA-N 0.000 description 2
- HJJVWDZTPSJGRC-UHFFFAOYSA-N 2-[5-bromo-2-(2-piperidin-4-ylethylamino)pyrimidin-4-yl]-n-methyl-1-benzothiophene-4-carboxamide Chemical compound C=1C=2C(C(=O)NC)=CC=CC=2SC=1C(C(=CN=1)Br)=NC=1NCCC1CCNCC1 HJJVWDZTPSJGRC-UHFFFAOYSA-N 0.000 description 2
- CMDLUUFAOGOPPR-UHFFFAOYSA-N 2-[5-chloro-2-(2-piperidin-4-ylethylamino)pyrimidin-4-yl]-1-benzothiophene-4-carboxamide Chemical compound C=1C=2C(C(=O)N)=CC=CC=2SC=1C(C(=CN=1)Cl)=NC=1NCCC1CCNCC1 CMDLUUFAOGOPPR-UHFFFAOYSA-N 0.000 description 2
- YDTPNVWZLNWQGE-UHFFFAOYSA-N 2-[5-chloro-2-(3-piperidin-4-ylpropylamino)pyrimidin-4-yl]-n-cyclopropyl-1-benzothiophene-4-carboxamide Chemical compound N1=C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)C(Cl)=CN=C1NCCCC1CCNCC1 YDTPNVWZLNWQGE-UHFFFAOYSA-N 0.000 description 2
- GNBXQPDQVRESKE-UHFFFAOYSA-N 2-[5-chloro-2-[3-(1-cyclopropylpiperidin-4-yl)propylamino]pyrimidin-4-yl]-n-cyclopropyl-1-benzothiophene-4-carboxamide;dihydrochloride Chemical compound Cl.Cl.N1=C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)C(Cl)=CN=C1NCCCC(CC1)CCN1C1CC1 GNBXQPDQVRESKE-UHFFFAOYSA-N 0.000 description 2
- GSDNLQXGDYOHQY-UHFFFAOYSA-N 2-[5-chloro-2-[3-(1-formylpiperidin-4-yl)propylamino]pyrimidin-4-yl]-n-cyclopropyl-1-benzothiophene-4-carboxamide Chemical compound N1=C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)C(Cl)=CN=C1NCCCC1CCN(C=O)CC1 GSDNLQXGDYOHQY-UHFFFAOYSA-N 0.000 description 2
- JTBHFIKRUNZZGI-UHFFFAOYSA-N 2-[5-chloro-2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-1-benzothiophene-6-carbonitrile Chemical compound C1CN(C)CCN1CCCNC1=NC=C(Cl)C(C=2SC3=CC(=CC=C3C=2)C#N)=N1 JTBHFIKRUNZZGI-UHFFFAOYSA-N 0.000 description 2
- OWZZEGNPUZFEDB-UHFFFAOYSA-N 2-[5-methyl-2-(3-piperidin-4-ylpropylamino)pyrimidin-4-yl]-1-benzothiophene-4-carboxamide Chemical compound N1=C(C=2SC3=CC=CC(=C3C=2)C(N)=O)C(C)=CN=C1NCCCC1CCNCC1 OWZZEGNPUZFEDB-UHFFFAOYSA-N 0.000 description 2
- SDGKLCXEALVORS-UHFFFAOYSA-N 2-[5-methyl-2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-1-benzothiophen-4-ol Chemical compound C1CN(C)CCN1CCCNC1=NC=C(C)C(C=2SC3=CC=CC(O)=C3C=2)=N1 SDGKLCXEALVORS-UHFFFAOYSA-N 0.000 description 2
- PIVREVAINVCXEA-UHFFFAOYSA-N 2-chloro-4-(7-chloro-1-benzothiophen-2-yl)pyrimidine Chemical compound ClC1=NC=CC(C=2SC3=C(Cl)C=CC=C3C=2)=N1 PIVREVAINVCXEA-UHFFFAOYSA-N 0.000 description 2
- APRMCBSTMFKLEI-UHFFFAOYSA-N 2-chloro-5-methylpyrimidine Chemical compound CC1=CN=C(Cl)N=C1 APRMCBSTMFKLEI-UHFFFAOYSA-N 0.000 description 2
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 2
- JMTMSDXUXJISAY-UHFFFAOYSA-N 2H-benzotriazol-4-ol Chemical compound OC1=CC=CC2=C1N=NN2 JMTMSDXUXJISAY-UHFFFAOYSA-N 0.000 description 2
- IEQHWSWDQPNZTK-UHFFFAOYSA-N 3-(1-methylpiperidin-4-yl)propan-1-amine Chemical compound CN1CCC(CCCN)CC1 IEQHWSWDQPNZTK-UHFFFAOYSA-N 0.000 description 2
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
- CUYKNJBYIJFRCU-UHFFFAOYSA-N 3-aminopyridine Chemical compound NC1=CC=CN=C1 CUYKNJBYIJFRCU-UHFFFAOYSA-N 0.000 description 2
- OUQOKWBXFGABHI-UHFFFAOYSA-N 4-(1-benzothiophen-2-yl)-5-methyl-n-(3-piperazin-1-ylpropyl)pyrimidin-2-amine Chemical compound N1=C(C=2SC3=CC=CC=C3C=2)C(C)=CN=C1NCCCN1CCNCC1 OUQOKWBXFGABHI-UHFFFAOYSA-N 0.000 description 2
- YVGQCEDIFPUVQD-UHFFFAOYSA-N 4-(2-aminoethyl)piperidine-1-carboxylic acid Chemical compound NCCC1CCN(C(O)=O)CC1 YVGQCEDIFPUVQD-UHFFFAOYSA-N 0.000 description 2
- MQXUITMEZRMWSB-UHFFFAOYSA-N 4-(3-hydroxypropyl)piperidine-1-carboxylic acid Chemical compound OCCCC1CCN(C(O)=O)CC1 MQXUITMEZRMWSB-UHFFFAOYSA-N 0.000 description 2
- IYLKFYPODUHWDR-UHFFFAOYSA-N 4-(6-bromo-1-benzothiophen-2-yl)-2-chloro-5-methylpyrimidine Chemical compound CC1=CN=C(Cl)N=C1C1=CC2=CC=C(Br)C=C2S1 IYLKFYPODUHWDR-UHFFFAOYSA-N 0.000 description 2
- CEWHUHJMWOVFSG-UHFFFAOYSA-N 4-(6-bromo-1-benzothiophen-2-yl)-5-chloro-n-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine Chemical compound C1CN(C)CCN1CCCNC1=NC=C(Cl)C(C=2SC3=CC(Br)=CC=C3C=2)=N1 CEWHUHJMWOVFSG-UHFFFAOYSA-N 0.000 description 2
- DBUNDHBBDRKOIS-UHFFFAOYSA-N 4-[6-(aminomethyl)-1-benzothiophen-2-yl]-n-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine Chemical compound C1CN(C)CCN1CCCNC1=NC=CC(C=2SC3=CC(CN)=CC=C3C=2)=N1 DBUNDHBBDRKOIS-UHFFFAOYSA-N 0.000 description 2
- JBSYDIKKOAPATG-UHFFFAOYSA-N 4-methoxy-n-(4-methoxyphenyl)-n-methylaniline Chemical compound C1=CC(OC)=CC=C1N(C)C1=CC=C(OC)C=C1 JBSYDIKKOAPATG-UHFFFAOYSA-N 0.000 description 2
- DHDMEZQLSRBWBI-UHFFFAOYSA-N 5-bromo-2-chloro-4-(7-methoxy-1-benzothiophen-2-yl)pyrimidine Chemical compound S1C=2C(OC)=CC=CC=2C=C1C1=NC(Cl)=NC=C1Br DHDMEZQLSRBWBI-UHFFFAOYSA-N 0.000 description 2
- XPGIBDJXEVAVTO-UHFFFAOYSA-N 5-bromo-2-chloropyrimidine Chemical compound ClC1=NC=C(Br)C=N1 XPGIBDJXEVAVTO-UHFFFAOYSA-N 0.000 description 2
- BJODFGTUQMOBBV-UHFFFAOYSA-N 5-chloro-n-[3-(4-methylpiperazin-1-yl)propyl]-4-[6-tri(propan-2-yl)silylsulfanyl-1-benzothiophen-2-yl]pyrimidin-2-amine Chemical compound S1C2=CC(S[Si](C(C)C)(C(C)C)C(C)C)=CC=C2C=C1C(C(=CN=1)Cl)=NC=1NCCCN1CCN(C)CC1 BJODFGTUQMOBBV-UHFFFAOYSA-N 0.000 description 2
- BGQQDEBLQKPBLS-UHFFFAOYSA-N 6-methylsulfanyl-1-benzothiophene Chemical compound CSC1=CC=C2C=CSC2=C1 BGQQDEBLQKPBLS-UHFFFAOYSA-N 0.000 description 2
- NOICDPBEDNMHQK-UHFFFAOYSA-N 7-bromo-1-benzothiophene Chemical compound BrC1=CC=CC2=C1SC=C2 NOICDPBEDNMHQK-UHFFFAOYSA-N 0.000 description 2
- 240000007124 Brassica oleracea Species 0.000 description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 2
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 2
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- GJNSFUSPTLTZLS-UHFFFAOYSA-N CC=1C(=NC(=NC=1)NCCCN1CCN(CC1)C)C1=CC2=C(S1)C=C(C=C2)S(=O)(=O)O Chemical compound CC=1C(=NC(=NC=1)NCCCN1CCN(CC1)C)C1=CC2=C(S1)C=C(C=C2)S(=O)(=O)O GJNSFUSPTLTZLS-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 102000019034 Chemokines Human genes 0.000 description 2
- 108010012236 Chemokines Proteins 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- DHCLVCXQIBBOPH-UHFFFAOYSA-N Glycerol 2-phosphate Chemical compound OCC(CO)OP(O)(O)=O DHCLVCXQIBBOPH-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 102000004889 Interleukin-6 Human genes 0.000 description 2
- 108090001005 Interleukin-6 Proteins 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- JWUXJYZVKZKLTJ-UHFFFAOYSA-N Triacetonamine Chemical compound CC1(C)CC(=O)CC(C)(C)N1 JWUXJYZVKZKLTJ-UHFFFAOYSA-N 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- PJSVSIWTLNJFKO-UHFFFAOYSA-N [2-(2-chloro-5-methylpyrimidin-4-yl)-1-benzothiophen-6-yl]-morpholin-4-ylmethanone Chemical compound CC1=CN=C(Cl)N=C1C1=CC2=CC=C(C(=O)N3CCOCC3)C=C2S1 PJSVSIWTLNJFKO-UHFFFAOYSA-N 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- HROGQYMZWGPHIB-UHFFFAOYSA-N bis(4-methoxyphenyl)methanamine Chemical compound C1=CC(OC)=CC=C1C(N)C1=CC=C(OC)C=C1 HROGQYMZWGPHIB-UHFFFAOYSA-N 0.000 description 2
- 125000001246 bromo group Chemical group Br* 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 230000036755 cellular response Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 239000012230 colorless oil Substances 0.000 description 2
- 239000010779 crude oil Substances 0.000 description 2
- WZHCOOQXZCIUNC-UHFFFAOYSA-N cyclandelate Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C(O)C1=CC=CC=C1 WZHCOOQXZCIUNC-UHFFFAOYSA-N 0.000 description 2
- YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 2
- XDUCRNVZHNFBLF-UHFFFAOYSA-N cyclopenta-1,3-diene diphenylphosphane iron(2+) Chemical compound [CH-]1C=CC=C1.[CH-]1C=CC=C1.[Fe+2].C1(=CC=CC=C1)PC1=CC=CC=C1 XDUCRNVZHNFBLF-UHFFFAOYSA-N 0.000 description 2
- SDEYRINHRILMPY-UHFFFAOYSA-N diazonio-[3-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]propyl]azanide Chemical compound CC(C)(C)OC(=O)N1CCN(CCCN=[N+]=[N-])CC1 SDEYRINHRILMPY-UHFFFAOYSA-N 0.000 description 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 2
- QKIUAMUSENSFQQ-UHFFFAOYSA-N dimethylazanide Chemical compound C[N-]C QKIUAMUSENSFQQ-UHFFFAOYSA-N 0.000 description 2
- 239000012971 dimethylpiperazine Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 150000005694 halopyrimidines Chemical class 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229940100601 interleukin-6 Drugs 0.000 description 2
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 2
- SRJOCJYGOFTFLH-UHFFFAOYSA-N isonipecotic acid Chemical compound OC(=O)C1CCNCC1 SRJOCJYGOFTFLH-UHFFFAOYSA-N 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 2
- 229910052808 lithium carbonate Inorganic materials 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- LJEKEROHNAFUGD-UHFFFAOYSA-N methyl 1-benzothiophene-4-carboxylate Chemical compound COC(=O)C1=CC=CC2=C1C=CS2 LJEKEROHNAFUGD-UHFFFAOYSA-N 0.000 description 2
- LUAQLMFNQYOVPQ-UHFFFAOYSA-N methyl 1-benzothiophene-6-carboxylate Chemical compound COC(=O)C1=CC=C2C=CSC2=C1 LUAQLMFNQYOVPQ-UHFFFAOYSA-N 0.000 description 2
- KWPDOYBIQDYAFZ-UHFFFAOYSA-N methyl 2-(2,5-dichloropyrimidin-4-yl)-1-benzothiophene-6-carboxylate Chemical compound S1C2=CC(C(=O)OC)=CC=C2C=C1C1=NC(Cl)=NC=C1Cl KWPDOYBIQDYAFZ-UHFFFAOYSA-N 0.000 description 2
- KFKSAAAAZWCNTF-UHFFFAOYSA-N methyl 2-(2-chloro-5-methylpyrimidin-4-yl)-1-benzothiophene-6-carboxylate Chemical compound S1C2=CC(C(=O)OC)=CC=C2C=C1C1=NC(Cl)=NC=C1C KFKSAAAAZWCNTF-UHFFFAOYSA-N 0.000 description 2
- WYSBFEHXFISSGN-UHFFFAOYSA-N methyl 2-(2-chloropyrimidin-4-yl)-1-benzothiophene-4-carboxylate Chemical compound C=1C=2C(C(=O)OC)=CC=CC=2SC=1C1=CC=NC(Cl)=N1 WYSBFEHXFISSGN-UHFFFAOYSA-N 0.000 description 2
- PRTPXMSRPUOBDP-UHFFFAOYSA-N methyl 2-[5-chloro-2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-1-benzothiophene-4-carboxylate Chemical compound C=1C=2C(C(=O)OC)=CC=CC=2SC=1C(C(=CN=1)Cl)=NC=1NCCCN1CCN(C)CC1 PRTPXMSRPUOBDP-UHFFFAOYSA-N 0.000 description 2
- ACHZNZUMVVFBHW-UHFFFAOYSA-N methyl 2-[5-chloro-2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-1-benzothiophene-6-carboxylate Chemical compound S1C2=CC(C(=O)OC)=CC=C2C=C1C(C(=CN=1)Cl)=NC=1NCCCN1CCN(C)CC1 ACHZNZUMVVFBHW-UHFFFAOYSA-N 0.000 description 2
- MOYOANKQRNLYLF-UHFFFAOYSA-N methyl 2-[5-methyl-2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-1-benzothiophene-6-carboxylate Chemical compound S1C2=CC(C(=O)OC)=CC=C2C=C1C(C(=CN=1)C)=NC=1NCCCN1CCN(C)CC1 MOYOANKQRNLYLF-UHFFFAOYSA-N 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- KOCBLPAULFFOST-UHFFFAOYSA-N n,n-dimethyl-2-[5-methyl-2-[2-(1-methylpiperidin-4-yl)ethylamino]pyrimidin-4-yl]-1-benzothiophene-6-carboxamide;dihydrochloride Chemical compound Cl.Cl.S1C2=CC(C(=O)N(C)C)=CC=C2C=C1C(C(=CN=1)C)=NC=1NCCC1CCN(C)CC1 KOCBLPAULFFOST-UHFFFAOYSA-N 0.000 description 2
- PYBVUVHCDKNZAR-UHFFFAOYSA-N n-[3-[[5-chloro-4-[4-(cyclopropylcarbamoyl)-1-benzothiophen-2-yl]pyrimidin-2-yl]amino]propyl]-1-methylpiperidine-4-carboxamide Chemical compound C1CN(C)CCC1C(=O)NCCCNC1=NC=C(Cl)C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)=N1 PYBVUVHCDKNZAR-UHFFFAOYSA-N 0.000 description 2
- MWENITABFGJZIJ-UHFFFAOYSA-N n-[[4-(aminomethyl)cyclohexyl]methyl]-4-(1-benzothiophen-2-yl)pyrimidin-2-amine Chemical compound C1CC(CN)CCC1CNC1=NC=CC(C=2SC3=CC=CC=C3C=2)=N1 MWENITABFGJZIJ-UHFFFAOYSA-N 0.000 description 2
- IFHXMLXGQUKVSB-UHFFFAOYSA-N n-cyclopropyl-2-[5-methyl-2-(3-piperidin-3-ylpropylamino)pyrimidin-4-yl]-1-benzothiophene-4-carboxamide Chemical compound N1=C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)C(C)=CN=C1NCCCC1CCCNC1 IFHXMLXGQUKVSB-UHFFFAOYSA-N 0.000 description 2
- HSUAOOWDEZTLIJ-UHFFFAOYSA-N n-cyclopropyl-2-[5-methyl-2-(3-piperidin-4-ylpropylamino)pyrimidin-4-yl]-1-benzothiophene-4-carboxamide Chemical compound N1=C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)C(C)=CN=C1NCCCC1CCNCC1 HSUAOOWDEZTLIJ-UHFFFAOYSA-N 0.000 description 2
- AWQVKAURKXXOCG-UHFFFAOYSA-N n-cyclopropylformamide Chemical compound O=CNC1CC1 AWQVKAURKXXOCG-UHFFFAOYSA-N 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 2
- IIKFXOLJMNWWCH-UHFFFAOYSA-N piperidine-1,4-dicarboxylic acid Chemical compound OC(=O)C1CCN(C(O)=O)CC1 IIKFXOLJMNWWCH-UHFFFAOYSA-N 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- LJCNRYVRMXRIQR-OLXYHTOASA-L potassium sodium L-tartrate Chemical class [Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O LJCNRYVRMXRIQR-OLXYHTOASA-L 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000001012 protector Effects 0.000 description 2
- WRHZVMBBRYBTKZ-UHFFFAOYSA-N pyrrole-2-carboxylic acid Chemical compound OC(=O)C1=CC=CN1 WRHZVMBBRYBTKZ-UHFFFAOYSA-N 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 229940054269 sodium pyruvate Drugs 0.000 description 2
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 230000000707 stereoselective effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- AJTYGHSVRUDXKS-UHFFFAOYSA-N tert-butyl 3-(3-aminopropyl)piperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCCC(CCCN)C1 AJTYGHSVRUDXKS-UHFFFAOYSA-N 0.000 description 2
- UHLAQCKNCBYTIF-UHFFFAOYSA-N tert-butyl 3-propan-2-ylpiperazine-1-carboxylate Chemical compound CC(C)C1CN(C(=O)OC(C)(C)C)CCN1 UHLAQCKNCBYTIF-UHFFFAOYSA-N 0.000 description 2
- ZXAWHVKPOIYDRU-UHFFFAOYSA-N tert-butyl 4-(2-aminoethyl)-4-methylpiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(C)(CCN)CC1 ZXAWHVKPOIYDRU-UHFFFAOYSA-N 0.000 description 2
- LBQDLHPFISVBRU-UHFFFAOYSA-N tert-butyl 4-(2-aminoethyl)piperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(CCN)CC1 LBQDLHPFISVBRU-UHFFFAOYSA-N 0.000 description 2
- XXDVSPISMICMLG-UHFFFAOYSA-N tert-butyl 4-(2-cyano-1-hydroxyethyl)-4-methylpiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(C)(C(O)CC#N)CC1 XXDVSPISMICMLG-UHFFFAOYSA-N 0.000 description 2
- RUVUXLNBUSXMDH-UHFFFAOYSA-N tert-butyl 4-(2-cyanoacetyl)-4-methylpiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(C)(C(=O)CC#N)CC1 RUVUXLNBUSXMDH-UHFFFAOYSA-N 0.000 description 2
- JDAXWOQUXAAJHV-UHFFFAOYSA-N tert-butyl 4-(3-aminopropyl)-3-propan-2-ylpiperazine-1-carboxylate Chemical compound CC(C)C1CN(C(=O)OC(C)(C)C)CCN1CCCN JDAXWOQUXAAJHV-UHFFFAOYSA-N 0.000 description 2
- RORXMFNDHUAQSA-UHFFFAOYSA-N tert-butyl 4-(3-aminopropyl)-4-methylpiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(C)(CCCN)CC1 RORXMFNDHUAQSA-UHFFFAOYSA-N 0.000 description 2
- PRMYRRODTPOYIU-UHFFFAOYSA-N tert-butyl 4-(cyanomethyl)-4-methylpiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(C)(CC#N)CC1 PRMYRRODTPOYIU-UHFFFAOYSA-N 0.000 description 2
- YFYSPIRFZKBBAU-UHFFFAOYSA-N tert-butyl 4-(hydroxymethyl)-4-methylpiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(C)(CO)CC1 YFYSPIRFZKBBAU-UHFFFAOYSA-N 0.000 description 2
- UZLNKOXBXNATQR-UHFFFAOYSA-N tert-butyl 4-[3-[[4-(4-methoxycarbonyl-1-benzothiophen-2-yl)pyrimidin-2-yl]amino]propyl]piperazine-1-carboxylate Chemical compound C=1C=2C(C(=O)OC)=CC=CC=2SC=1C(N=1)=CC=NC=1NCCCN1CCN(C(=O)OC(C)(C)C)CC1 UZLNKOXBXNATQR-UHFFFAOYSA-N 0.000 description 2
- NSDBQCPRIOIETA-UHFFFAOYSA-N tert-butyl n-(1-benzothiophen-6-yl)carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC=C2C=CSC2=C1 NSDBQCPRIOIETA-UHFFFAOYSA-N 0.000 description 2
- MPGWYKMGSVBFRZ-UHFFFAOYSA-N tert-butyl n-(1-benzothiophen-6-ylmethyl)carbamate Chemical compound CC(C)(C)OC(=O)NCC1=CC=C2C=CSC2=C1 MPGWYKMGSVBFRZ-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 238000000844 transformation Methods 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- BZMMRNKDONDVIB-UHFFFAOYSA-N (1-ethoxycyclopropyl)oxy-trimethylsilane Chemical compound CCOC1(O[Si](C)(C)C)CC1 BZMMRNKDONDVIB-UHFFFAOYSA-N 0.000 description 1
- DOMQFIFVDIAOOT-ROUUACIJSA-N (2S,3R)-N-[4-(2,6-dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-1,2,4-triazol-3-yl]-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide Chemical compound COC1=C(C(=CC=C1)OC)N1C(=NN=C1C=1C=NC=C(C=1)C)NS(=O)(=O)[C@@H](C)[C@H](C)C1=NC=C(C=N1)C DOMQFIFVDIAOOT-ROUUACIJSA-N 0.000 description 1
- HRMRQBJUFWFQLX-ZETCQYMHSA-N (3s)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-3-carboxylic acid Chemical compound CC(C)(C)OC(=O)N1CC[C@H](C(O)=O)C1 HRMRQBJUFWFQLX-ZETCQYMHSA-N 0.000 description 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 1
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 description 1
- UKGJZDSUJSPAJL-YPUOHESYSA-N (e)-n-[(1r)-1-[3,5-difluoro-4-(methanesulfonamido)phenyl]ethyl]-3-[2-propyl-6-(trifluoromethyl)pyridin-3-yl]prop-2-enamide Chemical compound CCCC1=NC(C(F)(F)F)=CC=C1\C=C\C(=O)N[C@H](C)C1=CC(F)=C(NS(C)(=O)=O)C(F)=C1 UKGJZDSUJSPAJL-YPUOHESYSA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- VEFLKXRACNJHOV-UHFFFAOYSA-N 1,3-dibromopropane Chemical compound BrCCCBr VEFLKXRACNJHOV-UHFFFAOYSA-N 0.000 description 1
- BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- JWOHBPPVVDQMKB-UHFFFAOYSA-N 1-[(2-methylpropan-2-yl)oxycarbonyl]piperidine-4-carboxylic acid Chemical compound CC(C)(C)OC(=O)N1CCC(C(O)=O)CC1 JWOHBPPVVDQMKB-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- ZHOYPWQBYVTFJU-UHFFFAOYSA-N 1-[2-[5-chloro-2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-1-benzothiophen-6-yl]pyrrolidin-2-one Chemical compound C1CN(C)CCN1CCCNC1=NC=C(Cl)C(C=2SC3=CC(=CC=C3C=2)N2C(CCC2)=O)=N1 ZHOYPWQBYVTFJU-UHFFFAOYSA-N 0.000 description 1
- JTLAIKFGRHDNQM-UHFFFAOYSA-N 1-bromo-2-fluoroethane Chemical compound FCCBr JTLAIKFGRHDNQM-UHFFFAOYSA-N 0.000 description 1
- BYNCVQFGWIVRSK-UHFFFAOYSA-N 1-chloro-2-(2,2-diethoxyethylsulfanyl)benzene Chemical compound CCOC(OCC)CSC1=CC=CC=C1Cl BYNCVQFGWIVRSK-UHFFFAOYSA-N 0.000 description 1
- OQURWGJAWSLGQG-UHFFFAOYSA-N 1-isocyanatopropane Chemical compound CCCN=C=O OQURWGJAWSLGQG-UHFFFAOYSA-N 0.000 description 1
- FXHRAKUEZPSMLJ-UHFFFAOYSA-N 1-methyl-1,4-diazepane Chemical compound CN1CCCNCC1 FXHRAKUEZPSMLJ-UHFFFAOYSA-N 0.000 description 1
- XTVJBGBETZFXJR-UHFFFAOYSA-N 1-o-tert-butyl 4-o-methyl 4-ethylpiperidine-1,4-dicarboxylate Chemical compound COC(=O)C1(CC)CCN(C(=O)OC(C)(C)C)CC1 XTVJBGBETZFXJR-UHFFFAOYSA-N 0.000 description 1
- WHKWMTXTYKVFLK-UHFFFAOYSA-N 1-propan-2-ylpiperazine Chemical compound CC(C)N1CCNCC1 WHKWMTXTYKVFLK-UHFFFAOYSA-N 0.000 description 1
- KAESVJOAVNADME-UHFFFAOYSA-N 1H-pyrrole Natural products C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 1
- QXYLYYZZWZQACI-UHFFFAOYSA-N 2,3,4,5-tetrafluorophenol Chemical compound OC1=CC(F)=C(F)C(F)=C1F QXYLYYZZWZQACI-UHFFFAOYSA-N 0.000 description 1
- DPVIABCMTHHTGB-UHFFFAOYSA-N 2,4,6-trichloropyrimidine Chemical compound ClC1=CC(Cl)=NC(Cl)=N1 DPVIABCMTHHTGB-UHFFFAOYSA-N 0.000 description 1
- WHPFEQUEHBULBW-UHFFFAOYSA-N 2,4-dichloro-5-fluoropyrimidine Chemical compound FC1=CN=C(Cl)N=C1Cl WHPFEQUEHBULBW-UHFFFAOYSA-N 0.000 description 1
- HDYLFJCDQDBFHH-UHFFFAOYSA-N 2-(1-benzothiophen-2-yl)pyrimidine Chemical class S1C2=CC=CC=C2C=C1C1=NC=CC=N1 HDYLFJCDQDBFHH-UHFFFAOYSA-N 0.000 description 1
- BGXFCFUXFLXDCW-UHFFFAOYSA-N 2-(1h-indol-3-yl)-n-[2-[2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-1-benzothiophen-6-yl]acetamide Chemical compound C1CN(C)CCN1CCCNC1=NC=CC(C=2SC3=CC(NC(=O)CC=4C5=CC=CC=C5NC=4)=CC=C3C=2)=N1 BGXFCFUXFLXDCW-UHFFFAOYSA-N 0.000 description 1
- LCSNESAHHGTVLP-UHFFFAOYSA-N 2-(2,2,6,6-tetramethylpiperidin-4-yl)ethanamine Chemical compound CC1(C)CC(CCN)CC(C)(C)N1 LCSNESAHHGTVLP-UHFFFAOYSA-N 0.000 description 1
- GETPGYLMOPSRJB-UHFFFAOYSA-N 2-(2,2,6,6-tetramethylpiperidin-4-ylidene)acetonitrile Chemical compound CC1(C)CC(=CC#N)CC(C)(C)N1 GETPGYLMOPSRJB-UHFFFAOYSA-N 0.000 description 1
- CHZXTOCAICMPQR-UHFFFAOYSA-N 2-(2-bromoethyl)isoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(CCBr)C(=O)C2=C1 CHZXTOCAICMPQR-UHFFFAOYSA-N 0.000 description 1
- VHIBPXQHJVJKFW-UHFFFAOYSA-N 2-(2-chloro-5-methylpyrimidin-4-yl)-1-benzothiophene-6-carboxylic acid Chemical compound CC1=CN=C(Cl)N=C1C1=CC2=CC=C(C(O)=O)C=C2S1 VHIBPXQHJVJKFW-UHFFFAOYSA-N 0.000 description 1
- OTQWARRTIDUGAG-UHFFFAOYSA-N 2-[2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-1-benzothiophen-7-ol Chemical compound C1CN(C)CCN1CCCNC1=NC=CC(C=2SC3=C(O)C=CC=C3C=2)=N1 OTQWARRTIDUGAG-UHFFFAOYSA-N 0.000 description 1
- UJXILMHPEPQYJG-UHFFFAOYSA-N 2-[2-[3-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]propylamino]pyrimidin-4-yl]-1-benzothiophene-4-carboxylic acid;dihydrochloride Chemical compound Cl.Cl.C1CN(C(=O)OC(C)(C)C)CCN1CCCNC1=NC=CC(C=2SC3=CC=CC(=C3C=2)C(O)=O)=N1 UJXILMHPEPQYJG-UHFFFAOYSA-N 0.000 description 1
- ILMMRAKJRXQCOE-OKILXGFUSA-N 2-[3-[(3r,5s)-3,4,5-trimethylpiperazin-1-yl]propyl]isoindole-1,3-dione Chemical compound C1[C@@H](C)N(C)[C@@H](C)CN1CCCN1C(=O)C2=CC=CC=C2C1=O ILMMRAKJRXQCOE-OKILXGFUSA-N 0.000 description 1
- JFMUYMRGTULEGV-BETUJISGSA-N 2-[3-[(3r,5s)-3,5-dimethylpiperazin-1-yl]propyl]isoindole-1,3-dione Chemical compound C1[C@@H](C)N[C@@H](C)CN1CCCN1C(=O)C2=CC=CC=C2C1=O JFMUYMRGTULEGV-BETUJISGSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- LIWWBZALVHNYAM-UHFFFAOYSA-N 2-[5-bromo-2-[2-(4-methylpiperidin-4-yl)ethylamino]pyrimidin-4-yl]-n-cyclopropyl-1-benzothiophene-4-carboxamide;dihydrochloride Chemical compound Cl.Cl.N=1C=C(Br)C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)=NC=1NCCC1(C)CCNCC1 LIWWBZALVHNYAM-UHFFFAOYSA-N 0.000 description 1
- CELRTNZNLWFLOO-UHFFFAOYSA-N 2-[5-chloro-2-(2-piperidin-4-ylethylamino)pyrimidin-4-yl]-n-cyclopropyl-1-benzothiophene-4-carboxamide Chemical compound N1=C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)C(Cl)=CN=C1NCCC1CCNCC1 CELRTNZNLWFLOO-UHFFFAOYSA-N 0.000 description 1
- QLUJHGUCVDOQHJ-UHFFFAOYSA-N 2-[5-chloro-2-(2-piperidin-4-ylethylamino)pyrimidin-4-yl]-n-cyclopropyl-1-benzothiophene-4-carboxamide;dihydrochloride Chemical compound Cl.Cl.N1=C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)C(Cl)=CN=C1NCCC1CCNCC1 QLUJHGUCVDOQHJ-UHFFFAOYSA-N 0.000 description 1
- QMGXBFGQSMSXST-UHFFFAOYSA-N 2-[5-chloro-2-[2-(1-methylpiperidin-4-yl)ethylamino]pyrimidin-4-yl]-1-benzothiophene-4-carboxamide Chemical compound C1CN(C)CCC1CCNC1=NC=C(Cl)C(C=2SC3=CC=CC(=C3C=2)C(N)=O)=N1 QMGXBFGQSMSXST-UHFFFAOYSA-N 0.000 description 1
- ZVJBUTCWBWQMNW-UHFFFAOYSA-N 2-[5-chloro-2-[2-(methylamino)ethylamino]pyrimidin-4-yl]-n-cyclopropyl-1-benzothiophene-4-carboxamide;dihydrochloride Chemical compound Cl.Cl.CNCCNC1=NC=C(Cl)C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)=N1 ZVJBUTCWBWQMNW-UHFFFAOYSA-N 0.000 description 1
- UZPFWPOFJGWIKG-CQSZACIVSA-N 2-[5-chloro-2-[2-[(2r)-2-methylpiperazin-1-yl]ethylamino]pyrimidin-4-yl]-n-cyclopropyl-1-benzothiophene-4-carboxamide Chemical compound C[C@@H]1CNCCN1CCNC1=NC=C(Cl)C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)=N1 UZPFWPOFJGWIKG-CQSZACIVSA-N 0.000 description 1
- SQLLULILLYDOSH-INIZCTEOSA-N 2-[5-chloro-2-[2-[(3s)-3-(dimethylamino)pyrrolidin-1-yl]ethylamino]pyrimidin-4-yl]-n-cyclopropyl-1-benzothiophene-4-carboxamide Chemical compound C1[C@@H](N(C)C)CCN1CCNC1=NC=C(Cl)C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)=N1 SQLLULILLYDOSH-INIZCTEOSA-N 0.000 description 1
- IWOJDGTZMJQYJY-UHFFFAOYSA-N 2-[5-chloro-2-[3-(1-ethylpiperidin-4-yl)propylamino]pyrimidin-4-yl]-n-cyclopropyl-1-benzothiophene-4-carboxamide;dihydrochloride Chemical compound Cl.Cl.C1CN(CC)CCC1CCCNC1=NC=C(Cl)C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)=N1 IWOJDGTZMJQYJY-UHFFFAOYSA-N 0.000 description 1
- ZHSOLMNPPPPDJJ-UHFFFAOYSA-N 2-[5-chloro-2-[3-(2-propan-2-ylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-n-cyclopropyl-1-benzothiophene-4-carboxamide Chemical compound CC(C)C1CNCCN1CCCNC1=NC=C(Cl)C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)=N1 ZHSOLMNPPPPDJJ-UHFFFAOYSA-N 0.000 description 1
- YNDYVWWDDCGIFZ-UHFFFAOYSA-N 2-[5-chloro-2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-1-benzothiophene-4-carbohydrazide Chemical compound C1CN(C)CCN1CCCNC1=NC=C(Cl)C(C=2SC3=CC=CC(=C3C=2)C(=O)NN)=N1 YNDYVWWDDCGIFZ-UHFFFAOYSA-N 0.000 description 1
- IOIVHECWCSBQQW-UHFFFAOYSA-N 2-[5-chloro-2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-1-benzothiophene-4-carboxamide Chemical compound C1CN(C)CCN1CCCNC1=NC=C(Cl)C(C=2SC3=CC=CC(=C3C=2)C(N)=O)=N1 IOIVHECWCSBQQW-UHFFFAOYSA-N 0.000 description 1
- ISIFOOHKURTKQS-UHFFFAOYSA-N 2-[5-chloro-2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-1-benzothiophene-6-carboxamide Chemical compound C1CN(C)CCN1CCCNC1=NC=C(Cl)C(C=2SC3=CC(=CC=C3C=2)C(N)=O)=N1 ISIFOOHKURTKQS-UHFFFAOYSA-N 0.000 description 1
- RYVXLQATUCSZGI-UHFFFAOYSA-N 2-[5-chloro-2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-1-benzothiophene-6-sulfonamide Chemical compound C1CN(C)CCN1CCCNC1=NC=C(Cl)C(C=2SC3=CC(=CC=C3C=2)S(N)(=O)=O)=N1 RYVXLQATUCSZGI-UHFFFAOYSA-N 0.000 description 1
- BNFAYJPQCPZQND-UHFFFAOYSA-N 2-[5-chloro-2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-n-cyclopropyl-1-benzothiophene-4-carboxamide Chemical compound C1CN(C)CCN1CCCNC1=NC=C(Cl)C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)=N1 BNFAYJPQCPZQND-UHFFFAOYSA-N 0.000 description 1
- IEXCRLAGBWKVPW-UHFFFAOYSA-N 2-[5-chloro-2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-n-cyclopropyl-1-benzothiophene-4-carboxamide;trihydrochloride Chemical compound Cl.Cl.Cl.C1CN(C)CCN1CCCNC1=NC=C(Cl)C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)=N1 IEXCRLAGBWKVPW-UHFFFAOYSA-N 0.000 description 1
- AAWJCVXFJHFNCY-UHFFFAOYSA-N 2-[5-chloro-2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-n-cyclopropyl-1-benzothiophene-6-carboxamide Chemical compound C1CN(C)CCN1CCCNC1=NC=C(Cl)C(C=2SC3=CC(=CC=C3C=2)C(=O)NC2CC2)=N1 AAWJCVXFJHFNCY-UHFFFAOYSA-N 0.000 description 1
- ZRCJBOWHXFUQNC-UHFFFAOYSA-N 2-[5-chloro-2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-n-cyclopropyl-7-hydroxy-1-benzothiophene-4-carboxamide Chemical compound C1CN(C)CCN1CCCNC1=NC=C(Cl)C(C=2SC3=C(O)C=CC(=C3C=2)C(=O)NC2CC2)=N1 ZRCJBOWHXFUQNC-UHFFFAOYSA-N 0.000 description 1
- KEZKOOVGITZYIW-UHFFFAOYSA-N 2-[5-chloro-2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-n-cyclopropyl-7-methoxy-1-benzothiophene-4-carboxamide Chemical compound C1=2C=C(C=3C(=CN=C(NCCCN4CCN(C)CC4)N=3)Cl)SC=2C(OC)=CC=C1C(=O)NC1CC1 KEZKOOVGITZYIW-UHFFFAOYSA-N 0.000 description 1
- KGUNSXVWZTYNES-CQSZACIVSA-N 2-[5-chloro-2-[3-[(2r)-2-methylpiperazin-1-yl]propylamino]pyrimidin-4-yl]-n-methyl-1-benzothiophene-4-carboxamide Chemical compound C=1C=2C(C(=O)NC)=CC=CC=2SC=1C(C(=CN=1)Cl)=NC=1NCCCN1CCNC[C@H]1C KGUNSXVWZTYNES-CQSZACIVSA-N 0.000 description 1
- QIJFUHVVFVGWRE-HNNXBMFYSA-N 2-[5-chloro-2-[3-[(2s)-2-methylpiperazin-1-yl]propylamino]pyrimidin-4-yl]-n-cyclopropyl-1-benzothiophene-4-carboxamide Chemical compound C[C@H]1CNCCN1CCCNC1=NC=C(Cl)C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)=N1 QIJFUHVVFVGWRE-HNNXBMFYSA-N 0.000 description 1
- AMCMQKRLNCGUSD-UHFFFAOYSA-N 2-[5-methyl-2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-1-benzothiophene-6-carboxamide Chemical compound C1CN(C)CCN1CCCNC1=NC=C(C)C(C=2SC3=CC(=CC=C3C=2)C(N)=O)=N1 AMCMQKRLNCGUSD-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 description 1
- LILXDMFJXYAKMK-UHFFFAOYSA-N 2-bromo-1,1-diethoxyethane Chemical compound CCOC(CBr)OCC LILXDMFJXYAKMK-UHFFFAOYSA-N 0.000 description 1
- PWOBDMNCYMQTCE-UHFFFAOYSA-N 2-chlorobenzenethiol Chemical compound SC1=CC=CC=C1Cl PWOBDMNCYMQTCE-UHFFFAOYSA-N 0.000 description 1
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 1
- KWMBADTWRIGGGG-UHFFFAOYSA-N 2-diethoxyphosphorylacetonitrile Chemical compound CCOP(=O)(CC#N)OCC KWMBADTWRIGGGG-UHFFFAOYSA-N 0.000 description 1
- HBCSNWKQNPKIHK-UHFFFAOYSA-N 2-propan-2-ylpiperazine Chemical compound CC(C)C1CNCCN1 HBCSNWKQNPKIHK-UHFFFAOYSA-N 0.000 description 1
- QYRYQOHCDCTGHJ-UHFFFAOYSA-N 3-(1-methylpiperidin-4-yl)propan-1-ol Chemical compound CN1CCC(CCCO)CC1 QYRYQOHCDCTGHJ-UHFFFAOYSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- XJKFIBMPFSXMBD-UHFFFAOYSA-N 3-(4-ethylpiperazin-1-yl)propan-1-amine Chemical compound CCN1CCN(CCCN)CC1 XJKFIBMPFSXMBD-UHFFFAOYSA-N 0.000 description 1
- UMHZXJMTGGOUJW-KDURUIRLSA-N 3-[(2r,6s)-4-benzhydryl-2,6-dimethylpiperazin-1-yl]propan-1-amine Chemical compound C1[C@@H](C)N(CCCN)[C@@H](C)CN1C(C=1C=CC=CC=1)C1=CC=CC=C1 UMHZXJMTGGOUJW-KDURUIRLSA-N 0.000 description 1
- DCMSEBJANHAWIS-DTORHVGOSA-N 3-[(3r,5s)-3,5-dimethylpiperazin-1-yl]propan-1-amine Chemical compound C[C@H]1CN(CCCN)C[C@@H](C)N1 DCMSEBJANHAWIS-DTORHVGOSA-N 0.000 description 1
- WFCMYKGHVOXWAT-AOOOYVTPSA-N 3-[(3s,5r)-3,4,5-trimethylpiperazin-1-yl]propan-1-amine Chemical compound C[C@H]1CN(CCCN)C[C@@H](C)N1C WFCMYKGHVOXWAT-AOOOYVTPSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 1
- HRCSHBSBIDCVPD-UHFFFAOYSA-N 3-[5-chloro-2-(2-piperidin-4-ylethylamino)pyrimidin-4-yl]-n-cyclopropyl-1-benzothiophene-4-carboxamide Chemical compound N1=C(C=2C3=C(C(=O)NC4CC4)C=CC=C3SC=2)C(Cl)=CN=C1NCCC1CCNCC1 HRCSHBSBIDCVPD-UHFFFAOYSA-N 0.000 description 1
- LRYIGPPTPAOLLP-UHFFFAOYSA-N 3-[5-chloro-2-(3-piperidin-4-ylpropylamino)pyrimidin-4-yl]-n-cyclopropyl-1-benzothiophene-4-carboxamide Chemical compound N1=C(C=2C3=C(C(=O)NC4CC4)C=CC=C3SC=2)C(Cl)=CN=C1NCCCC1CCNCC1 LRYIGPPTPAOLLP-UHFFFAOYSA-N 0.000 description 1
- JLZOGLJEROCEQF-UHFFFAOYSA-N 3-aminopropylcarbamic acid Chemical compound NCCCNC(O)=O JLZOGLJEROCEQF-UHFFFAOYSA-N 0.000 description 1
- UVLSCMIEPPWCHZ-UHFFFAOYSA-N 3-piperazin-1-ylpropan-1-amine Chemical class NCCCN1CCNCC1 UVLSCMIEPPWCHZ-UHFFFAOYSA-N 0.000 description 1
- DBIMLJDSPUCGGY-UHFFFAOYSA-N 3-piperidin-4-ylpropan-1-ol Chemical compound OCCCC1CCNCC1 DBIMLJDSPUCGGY-UHFFFAOYSA-N 0.000 description 1
- LWKZLZJKYNNKLP-UHFFFAOYSA-N 4-(1-benzothiophen-2-yl)-2,5-dichloropyrimidine Chemical compound ClC1=NC=C(Cl)C(C=2SC3=CC=CC=C3C=2)=N1 LWKZLZJKYNNKLP-UHFFFAOYSA-N 0.000 description 1
- VPOOBJFGHKJGPX-UHFFFAOYSA-N 4-(1-benzothiophen-2-yl)-2-chloro-5-methylpyrimidine Chemical compound CC1=CN=C(Cl)N=C1C1=CC2=CC=CC=C2S1 VPOOBJFGHKJGPX-UHFFFAOYSA-N 0.000 description 1
- OBBAUZDQEOVYOW-UHFFFAOYSA-N 4-(1-benzothiophen-2-yl)-5-methyl-n-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine Chemical compound C1CN(C)CCN1CCCNC1=NC=C(C)C(C=2SC3=CC=CC=C3C=2)=N1 OBBAUZDQEOVYOW-UHFFFAOYSA-N 0.000 description 1
- VDEYQSOFDSCWMV-UHFFFAOYSA-N 4-(1-benzothiophen-2-yl)pyrimidin-2-amine Chemical class NC1=NC=CC(C=2SC3=CC=CC=C3C=2)=N1 VDEYQSOFDSCWMV-UHFFFAOYSA-N 0.000 description 1
- AVDXVKBJGCBHRO-UHFFFAOYSA-N 4-(2-cyanoethenyl)-4-methylpiperidine-1-carboxylic acid Chemical compound C(#N)C=CC1(CCN(CC1)C(=O)O)C AVDXVKBJGCBHRO-UHFFFAOYSA-N 0.000 description 1
- WMPHGHBMKQZZOS-UHFFFAOYSA-N 4-(3-amino-1-hydroxypropyl)-4-methylpiperidine-1-carboxylic acid Chemical compound NCCC(O)C1(CCN(CC1)C(=O)O)C WMPHGHBMKQZZOS-UHFFFAOYSA-N 0.000 description 1
- OZHYBJXKUKBOFD-UHFFFAOYSA-N 4-(3-aminopropyl)-3-propan-2-ylpiperazine-1-carboxylic acid Chemical compound NCCCN1C(CN(CC1)C(=O)O)C(C)C OZHYBJXKUKBOFD-UHFFFAOYSA-N 0.000 description 1
- USEOPNPHQZGLCS-UHFFFAOYSA-N 4-(3-bromopropyl)piperazine-1-carboxylic acid Chemical compound OC(=O)N1CCN(CCCBr)CC1 USEOPNPHQZGLCS-UHFFFAOYSA-N 0.000 description 1
- NGMHGRQMZYHXPY-UHFFFAOYSA-N 4-(6-bromo-1-benzothiophen-2-yl)-5-methyl-n-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine Chemical compound C1CN(C)CCN1CCCNC1=NC=C(C)C(C=2SC3=CC(Br)=CC=C3C=2)=N1 NGMHGRQMZYHXPY-UHFFFAOYSA-N 0.000 description 1
- YWWYFPPMPJVOBO-UHFFFAOYSA-N 4-(7-bromo-1-benzothiophen-2-yl)-5-methyl-n-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine Chemical compound C1CN(C)CCN1CCCNC1=NC=C(C)C(C=2SC3=C(Br)C=CC=C3C=2)=N1 YWWYFPPMPJVOBO-UHFFFAOYSA-N 0.000 description 1
- HPJPKYPMYFGPLD-UHFFFAOYSA-N 4-(7-methoxy-1-benzothiophen-2-yl)-n-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine Chemical compound S1C=2C(OC)=CC=CC=2C=C1C(N=1)=CC=NC=1NCCCN1CCN(C)CC1 HPJPKYPMYFGPLD-UHFFFAOYSA-N 0.000 description 1
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 1
- VJPPLCNBDLZIFG-ZDUSSCGKSA-N 4-[(3S)-3-(but-2-ynoylamino)piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide Chemical compound C(C#CC)(=O)N[C@@H]1CN(CCC1)C1=C2C(=C(NC2=C(C=C1F)C(=O)N)C)C VJPPLCNBDLZIFG-ZDUSSCGKSA-N 0.000 description 1
- FKVLYBSVXOUMGQ-UHFFFAOYSA-N 4-[3-[[5-chloro-4-[4-(cyclopropylcarbamoyl)-1-benzothiophen-2-yl]pyrimidin-2-yl]amino]propyl]piperidine-1-carboxamide Chemical compound C1CN(C(=O)N)CCC1CCCNC1=NC=C(Cl)C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)=N1 FKVLYBSVXOUMGQ-UHFFFAOYSA-N 0.000 description 1
- UCAIPKGKLYDXHW-UHFFFAOYSA-N 4-methyl-4-(methylsulfonyloxymethyl)piperidine-1-carboxylic acid Chemical compound CS(=O)(=O)OCC1(CCN(CC1)C(=O)O)C UCAIPKGKLYDXHW-UHFFFAOYSA-N 0.000 description 1
- ZISGMPGRGVLFCN-UHFFFAOYSA-N 4-methylpiperidine-1,4-dicarboxylic acid Chemical compound OC(=O)C1(C)CCN(C(O)=O)CC1 ZISGMPGRGVLFCN-UHFFFAOYSA-N 0.000 description 1
- HDTNLIXKVAZDES-UHFFFAOYSA-N 5-bromo-4-(7-chloro-1-benzothiophen-2-yl)-n-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine Chemical compound C1CN(C)CCN1CCCNC1=NC=C(Br)C(C=2SC3=C(Cl)C=CC=C3C=2)=N1 HDTNLIXKVAZDES-UHFFFAOYSA-N 0.000 description 1
- ZBSTXLJAZUIERH-UHFFFAOYSA-N 5-bromo-4-(7-methoxy-1-benzothiophen-2-yl)-n-[3-(4-methylpiperazin-1-yl)propyl]pyrimidin-2-amine Chemical compound S1C=2C(OC)=CC=CC=2C=C1C(C(=CN=1)Br)=NC=1NCCCN1CCN(C)CC1 ZBSTXLJAZUIERH-UHFFFAOYSA-N 0.000 description 1
- KBLQDFSWVMPYEM-UHFFFAOYSA-N 5-bromo-6,7-dihydro-5h-1-benzothiophen-4-one Chemical compound O=C1C(Br)CCC2=C1C=CS2 KBLQDFSWVMPYEM-UHFFFAOYSA-N 0.000 description 1
- GJEKNELSXNSYAQ-UHFFFAOYSA-N 6,7-dihydro-5h-1-benzothiophen-4-one Chemical compound O=C1CCCC2=C1C=CS2 GJEKNELSXNSYAQ-UHFFFAOYSA-N 0.000 description 1
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
- JGNZTPXCNLSVER-UHFFFAOYSA-N 7-methoxy-1-benzothiophene-4-carbaldehyde Chemical compound COC1=CC=C(C=O)C2=C1SC=C2 JGNZTPXCNLSVER-UHFFFAOYSA-N 0.000 description 1
- ALVLZYRJVZWFLD-UHFFFAOYSA-N 7-methoxy-1-benzothiophene-4-carboxylic acid Chemical compound COC1=CC=C(C(O)=O)C2=C1SC=C2 ALVLZYRJVZWFLD-UHFFFAOYSA-N 0.000 description 1
- ZRPZPNYZFSJUPA-UHFFFAOYSA-N ARS-1620 Chemical compound Oc1cccc(F)c1-c1c(Cl)cc2c(ncnc2c1F)N1CCN(CC1)C(=O)C=C ZRPZPNYZFSJUPA-UHFFFAOYSA-N 0.000 description 1
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- NVCFXCQITUBROH-UHFFFAOYSA-N C1(CC1)NC(=O)C1=CC=CC=2SC(=CC=21)C1=NC(=NC=C1)Cl Chemical class C1(CC1)NC(=O)C1=CC=CC=2SC(=CC=21)C1=NC(=NC=C1)Cl NVCFXCQITUBROH-UHFFFAOYSA-N 0.000 description 1
- XPUMUPANWLLHLG-UHFFFAOYSA-N C1CNCCC1CCCNC2=NC=C(C(=N2)C3=CC4=CC=CC=C4S3)Cl Chemical compound C1CNCCC1CCCNC2=NC=C(C(=N2)C3=CC4=CC=CC=C4S3)Cl XPUMUPANWLLHLG-UHFFFAOYSA-N 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- MPKKUAASIFLPNH-UHFFFAOYSA-N Cl.Cl.ClC=1C(=NC(=NC1)NCCCC1CCN(CC1)C1CC1)C1=CC2=C(S1)C=CC=C2C(=O)O Chemical compound Cl.Cl.ClC=1C(=NC(=NC1)NCCCC1CCN(CC1)C1CC1)C1=CC2=C(S1)C=CC=C2C(=O)O MPKKUAASIFLPNH-UHFFFAOYSA-N 0.000 description 1
- CYHXGGFPSRSVPT-UHFFFAOYSA-N ClC1=NC=C(C(=N1)C1=CC2=C(S1)C=C(C=C2)S(=O)(=O)O)C Chemical compound ClC1=NC=C(C(=N1)C1=CC2=C(S1)C=C(C=C2)S(=O)(=O)O)C CYHXGGFPSRSVPT-UHFFFAOYSA-N 0.000 description 1
- 241000694440 Colpidium aqueous Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 101100508533 Drosophila melanogaster IKKbeta gene Proteins 0.000 description 1
- 208000009386 Experimental Arthritis Diseases 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 101150057269 IKBKB gene Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- BVZYOVNPDGDDLJ-UHFFFAOYSA-N N(=[N+]=[N-])CCCC1CCN(CC1)C(=O)O Chemical compound N(=[N+]=[N-])CCCC1CCN(CC1)C(=O)O BVZYOVNPDGDDLJ-UHFFFAOYSA-N 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- HYXUCTDZPOLDON-UHFFFAOYSA-N N-[2-[5-methyl-2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-1-benzothiophen-6-yl]methanesulfonamide Chemical compound C1CN(C)CCN1CCCNC1=NC=C(C)C(C=2SC3=CC(NS(C)(=O)=O)=CC=C3C=2)=N1 HYXUCTDZPOLDON-UHFFFAOYSA-N 0.000 description 1
- FEYNFHSRETUBEM-UHFFFAOYSA-N N-[3-(1,1-difluoroethyl)phenyl]-1-(4-methoxyphenyl)-3-methyl-5-oxo-4H-pyrazole-4-carboxamide Chemical compound COc1ccc(cc1)N1N=C(C)C(C(=O)Nc2cccc(c2)C(C)(F)F)C1=O FEYNFHSRETUBEM-UHFFFAOYSA-N 0.000 description 1
- YOPWCZMBRDMHLO-UHFFFAOYSA-N N-cyclopropylthiophene-3-carboxamide dihydrochloride Chemical compound C1CC1NC(=O)C2=CSC=C2.Cl.Cl YOPWCZMBRDMHLO-UHFFFAOYSA-N 0.000 description 1
- 101100030361 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pph-3 gene Proteins 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000219061 Rheum Species 0.000 description 1
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
- IHGOUUBITAJNOD-UHFFFAOYSA-N S1C2=C(C=C1)C=CC=C2.[Li] Chemical compound S1C2=C(C=C1)C=CC=C2.[Li] IHGOUUBITAJNOD-UHFFFAOYSA-N 0.000 description 1
- UYIJSAMECGPILT-UHFFFAOYSA-N S1C2=C(C=C1C1=NC(=NC=C1)NCC1CCC(CC1)CNC(O)=O)C=CC=C2 Chemical compound S1C2=C(C=C1C1=NC(=NC=C1)NCC1CCC(CC1)CNC(O)=O)C=CC=C2 UYIJSAMECGPILT-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 238000012338 Therapeutic targeting Methods 0.000 description 1
- 108010009583 Transforming Growth Factors Proteins 0.000 description 1
- 102000009618 Transforming Growth Factors Human genes 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- VITVWVGGFGPUDI-UHFFFAOYSA-N [2-(2,5-dichloropyrimidin-4-yl)-1-benzothiophen-6-yl]-morpholin-4-ylmethanone Chemical compound ClC1=NC=C(Cl)C(C=2SC3=CC(=CC=C3C=2)C(=O)N2CCOCC2)=N1 VITVWVGGFGPUDI-UHFFFAOYSA-N 0.000 description 1
- LRIXSMZQKNZXKC-UHFFFAOYSA-N [2-[2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-1-benzothiophen-6-yl]methylcarbamic acid Chemical compound CN1CCN(CC1)CCCNC1=NC=CC(=N1)C1=CC2=C(S1)C=C(C=C2)CNC(O)=O LRIXSMZQKNZXKC-UHFFFAOYSA-N 0.000 description 1
- FYFFPNFUVMBPRZ-UHFFFAOYSA-N [3-(methylcarbamoyl)phenyl]boronic acid Chemical compound CNC(=O)C1=CC=CC(B(O)O)=C1 FYFFPNFUVMBPRZ-UHFFFAOYSA-N 0.000 description 1
- OXIKYYJDTWKERT-UHFFFAOYSA-N [4-(aminomethyl)cyclohexyl]methanamine Chemical compound NCC1CCC(CN)CC1 OXIKYYJDTWKERT-UHFFFAOYSA-N 0.000 description 1
- JFBZPFYRPYOZCQ-UHFFFAOYSA-N [Li].[Al] Chemical compound [Li].[Al] JFBZPFYRPYOZCQ-UHFFFAOYSA-N 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 238000007098 aminolysis reaction Methods 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- RRIWSQXXBIFKQM-UHFFFAOYSA-N benzylcarbamic acid Chemical class OC(=O)NCC1=CC=CC=C1 RRIWSQXXBIFKQM-UHFFFAOYSA-N 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- OWIUPIRUAQMTTK-UHFFFAOYSA-N carbazic acid Chemical compound NNC(O)=O OWIUPIRUAQMTTK-UHFFFAOYSA-N 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 230000006315 carbonylation Effects 0.000 description 1
- 238000005810 carbonylation reaction Methods 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 238000003570 cell viability assay Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000012069 chiral reagent Substances 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- UTBIMNXEDGNJFE-UHFFFAOYSA-N collidine Natural products CC1=CC=C(C)C(C)=N1 UTBIMNXEDGNJFE-UHFFFAOYSA-N 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 1
- 229910052593 corundum Inorganic materials 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- ZFLAEHBSVFWEHW-UHFFFAOYSA-N cyanomethyl formate Chemical compound O=COCC#N ZFLAEHBSVFWEHW-UHFFFAOYSA-N 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- PFWWSGFPICCWGU-UHFFFAOYSA-N cyclopropanesulfonyl chloride Chemical compound ClS(=O)(=O)C1CC1 PFWWSGFPICCWGU-UHFFFAOYSA-N 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- MGHPNCMVUAKAIE-UHFFFAOYSA-N diphenylmethanamine Chemical compound C=1C=CC=CC=1C(N)C1=CC=CC=C1 MGHPNCMVUAKAIE-UHFFFAOYSA-N 0.000 description 1
- SXZIXHOMFPUIRK-UHFFFAOYSA-N diphenylmethanimine Chemical compound C=1C=CC=CC=1C(=N)C1=CC=CC=C1 SXZIXHOMFPUIRK-UHFFFAOYSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000003821 enantio-separation Methods 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- OCLXJTCGWSSVOE-UHFFFAOYSA-N ethanol etoh Chemical compound CCO.CCO OCLXJTCGWSSVOE-UHFFFAOYSA-N 0.000 description 1
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 1
- FCZCIXQGZOUIDN-UHFFFAOYSA-N ethyl 2-diethoxyphosphinothioyloxyacetate Chemical compound CCOC(=O)COP(=S)(OCC)OCC FCZCIXQGZOUIDN-UHFFFAOYSA-N 0.000 description 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 150000003948 formamides Chemical class 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 235000011167 hydrochloric acid Nutrition 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- NIZHERJWXFHGGU-UHFFFAOYSA-N isocyanato(trimethyl)silane Chemical compound C[Si](C)(C)N=C=O NIZHERJWXFHGGU-UHFFFAOYSA-N 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000000021 kinase assay Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 229910000103 lithium hydride Inorganic materials 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- WTKUWGIYJYXVAF-UHFFFAOYSA-N methyl 2-(2,5-dichloropyrimidin-4-yl)-1-benzothiophene-4-carboxylate Chemical compound C=1C=2C(C(=O)OC)=CC=CC=2SC=1C1=NC(Cl)=NC=C1Cl WTKUWGIYJYXVAF-UHFFFAOYSA-N 0.000 description 1
- HAMGRBXTJNITHG-UHFFFAOYSA-N methyl isocyanate Chemical compound CN=C=O HAMGRBXTJNITHG-UHFFFAOYSA-N 0.000 description 1
- NQMRYBIKMRVZLB-UHFFFAOYSA-N methylamine hydrochloride Chemical compound [Cl-].[NH3+]C NQMRYBIKMRVZLB-UHFFFAOYSA-N 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 210000000066 myeloid cell Anatomy 0.000 description 1
- CUCDQYMZTXKBSM-UHFFFAOYSA-N n,n-dimethyl-2-[5-methyl-2-(2-piperidin-4-ylethylamino)pyrimidin-4-yl]-1-benzothiophene-6-carboxamide Chemical compound S1C2=CC(C(=O)N(C)C)=CC=C2C=C1C(C(=CN=1)C)=NC=1NCCC1CCNCC1 CUCDQYMZTXKBSM-UHFFFAOYSA-N 0.000 description 1
- APHXCXVYXVVUHK-UHFFFAOYSA-N n,n-dimethyl-2-[5-methyl-2-(3-piperidin-4-ylpropylamino)pyrimidin-4-yl]-1-benzothiophene-6-carboxamide;dihydrochloride Chemical compound Cl.Cl.S1C2=CC(C(=O)N(C)C)=CC=C2C=C1C(C(=CN=1)C)=NC=1NCCCC1CCNCC1 APHXCXVYXVVUHK-UHFFFAOYSA-N 0.000 description 1
- CLQPKRMDCSZVLN-UHFFFAOYSA-N n,n-dimethyl-2-[5-methyl-2-[3-(1-methylpiperidin-4-yl)propylamino]pyrimidin-4-yl]-1-benzothiophene-6-carboxamide;dihydrochloride Chemical compound Cl.Cl.S1C2=CC(C(=O)N(C)C)=CC=C2C=C1C(C(=CN=1)C)=NC=1NCCCC1CCN(C)CC1 CLQPKRMDCSZVLN-UHFFFAOYSA-N 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- RMQRQMSITLRILH-UHFFFAOYSA-N n-(3-fluorophenyl)-2-[5-methyl-2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-1-benzothiophene-6-carboxamide Chemical compound C1CN(C)CCN1CCCNC1=NC=C(C)C(C=2SC3=CC(=CC=C3C=2)C(=O)NC=2C=C(F)C=CC=2)=N1 RMQRQMSITLRILH-UHFFFAOYSA-N 0.000 description 1
- FMASTMURQSHELY-UHFFFAOYSA-N n-(4-fluoro-2-methylphenyl)-3-methyl-n-[(2-methyl-1h-indol-4-yl)methyl]pyridine-4-carboxamide Chemical compound C1=CC=C2NC(C)=CC2=C1CN(C=1C(=CC(F)=CC=1)C)C(=O)C1=CC=NC=C1C FMASTMURQSHELY-UHFFFAOYSA-N 0.000 description 1
- GAPQRLMAHSWQML-UHFFFAOYSA-N n-[3-[[5-chloro-4-[4-(cyclopropylcarbamoyl)-1-benzothiophen-2-yl]pyrimidin-2-yl]amino]propyl]piperidine-4-carboxamide Chemical compound N1=C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)C(Cl)=CN=C1NCCCNC(=O)C1CCNCC1 GAPQRLMAHSWQML-UHFFFAOYSA-N 0.000 description 1
- QTDXEERFJRRPTJ-UHFFFAOYSA-N n-[bis(4-methoxyphenyl)methyl]-2-(2,5-dichloropyrimidin-4-yl)-1-benzothiophene-4-carboxamide Chemical compound C1=CC(OC)=CC=C1C(C=1C=CC(OC)=CC=1)NC(=O)C1=CC=CC2=C1C=C(C=1C(=CN=C(Cl)N=1)Cl)S2 QTDXEERFJRRPTJ-UHFFFAOYSA-N 0.000 description 1
- OSPBESXTTFIVNZ-UHFFFAOYSA-N n-[bis(4-methoxyphenyl)methyl]-2-(5-bromo-2-chloropyrimidin-4-yl)-1-benzothiophene-4-carboxamide Chemical compound C1=CC(OC)=CC=C1C(C=1C=CC(OC)=CC=1)NC(=O)C1=CC=CC2=C1C=C(C=1C(=CN=C(Cl)N=1)Br)S2 OSPBESXTTFIVNZ-UHFFFAOYSA-N 0.000 description 1
- WVLRKDBCINONDJ-UHFFFAOYSA-N n-benzhydryl-1-benzothiophene-6-sulfonamide Chemical compound C=1C=C2C=CSC2=CC=1S(=O)(=O)NC(C=1C=CC=CC=1)C1=CC=CC=C1 WVLRKDBCINONDJ-UHFFFAOYSA-N 0.000 description 1
- VLNASRYFZALUTL-UHFFFAOYSA-N n-benzhydryl-2-(2-chloro-5-methylpyrimidin-4-yl)-1-benzothiophene-6-sulfonamide Chemical compound CC1=CN=C(Cl)N=C1C1=CC2=CC=C(S(=O)(=O)NC(C=3C=CC=CC=3)C=3C=CC=CC=3)C=C2S1 VLNASRYFZALUTL-UHFFFAOYSA-N 0.000 description 1
- NNEBOSHGPDGMGV-UHFFFAOYSA-N n-benzhydryl-2-[5-methyl-2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-1-benzothiophene-6-sulfonamide Chemical compound C1CN(C)CCN1CCCNC1=NC=C(C)C(C=2SC3=CC(=CC=C3C=2)S(=O)(=O)NC(C=2C=CC=CC=2)C=2C=CC=CC=2)=N1 NNEBOSHGPDGMGV-UHFFFAOYSA-N 0.000 description 1
- GONITUBOVLBUMS-UHFFFAOYSA-N n-cyclopropyl-2-[2-(3-piperidin-4-ylpropylamino)pyrimidin-4-yl]-1-benzothiophene-4-carboxamide Chemical compound C=1C=CC=2SC(C=3N=C(NCCCC4CCNCC4)N=CC=3)=CC=2C=1C(=O)NC1CC1 GONITUBOVLBUMS-UHFFFAOYSA-N 0.000 description 1
- JLSYFKARTZORAE-UHFFFAOYSA-N n-cyclopropyl-2-[2-[3-(1-cyclopropylpiperidin-4-yl)propylamino]-5-methylpyrimidin-4-yl]-1-benzothiophene-4-carboxamide;dihydrochloride Chemical compound Cl.Cl.N1=C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)C(C)=CN=C1NCCCC(CC1)CCN1C1CC1 JLSYFKARTZORAE-UHFFFAOYSA-N 0.000 description 1
- UHYNOKBBWZKICK-UHFFFAOYSA-N n-cyclopropyl-2-[2-[3-(2,6-dimethylpiperazin-1-yl)propylamino]-5-methylpyrimidin-4-yl]-1-benzothiophene-4-carboxamide Chemical compound CC1CNCC(C)N1CCCNC1=NC=C(C)C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)=N1 UHYNOKBBWZKICK-UHFFFAOYSA-N 0.000 description 1
- IODXTJAAXJERBO-UHFFFAOYSA-N n-cyclopropyl-2-[5-fluoro-2-[2-(1-methylpiperidin-4-yl)ethylamino]pyrimidin-4-yl]-1-benzothiophene-4-carboxamide;dihydrochloride Chemical compound Cl.Cl.C1CN(C)CCC1CCNC1=NC=C(F)C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)=N1 IODXTJAAXJERBO-UHFFFAOYSA-N 0.000 description 1
- NKSCEUDEPLJZAL-MRXNPFEDSA-N n-cyclopropyl-2-[5-methyl-2-[2-[(2r)-2-methylpiperazin-1-yl]ethylamino]pyrimidin-4-yl]-1-benzothiophene-4-carboxamide Chemical compound C[C@@H]1CNCCN1CCNC1=NC=C(C)C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)=N1 NKSCEUDEPLJZAL-MRXNPFEDSA-N 0.000 description 1
- ZPPCVOFLGDUHFM-UHFFFAOYSA-N n-cyclopropyl-2-[5-methyl-2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-1-benzothiophene-4-carboxamide Chemical compound C1CN(C)CCN1CCCNC1=NC=C(C)C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)=N1 ZPPCVOFLGDUHFM-UHFFFAOYSA-N 0.000 description 1
- HFOWVIHUKBABOV-KRWDZBQOSA-N n-cyclopropyl-2-[5-methyl-2-[3-[(2s)-2-methylpiperazin-1-yl]propylamino]pyrimidin-4-yl]-1-benzothiophene-4-carboxamide Chemical compound C[C@H]1CNCCN1CCCNC1=NC=C(C)C(C=2SC3=CC=CC(=C3C=2)C(=O)NC2CC2)=N1 HFOWVIHUKBABOV-KRWDZBQOSA-N 0.000 description 1
- QKAYRXQSQSQEMK-UHFFFAOYSA-N n-methyl-1-benzothiophen-6-amine Chemical compound CNC1=CC=C2C=CSC2=C1 QKAYRXQSQSQEMK-UHFFFAOYSA-N 0.000 description 1
- JCRPGKHMLVNZBU-UHFFFAOYSA-N n-methyl-2-[5-methyl-2-(2-piperidin-4-ylethylamino)pyrimidin-4-yl]-1-benzothiophene-6-carboxamide;dihydrochloride Chemical compound Cl.Cl.S1C2=CC(C(=O)NC)=CC=C2C=C1C(C(=CN=1)C)=NC=1NCCC1CCNCC1 JCRPGKHMLVNZBU-UHFFFAOYSA-N 0.000 description 1
- SNKLKISJVIGMFX-UHFFFAOYSA-N n-methyl-2-[5-methyl-2-(3-piperidin-4-ylpropylamino)pyrimidin-4-yl]-1-benzothiophene-4-carboxamide Chemical compound C=1C=2C(C(=O)NC)=CC=CC=2SC=1C(C(=CN=1)C)=NC=1NCCCC1CCNCC1 SNKLKISJVIGMFX-UHFFFAOYSA-N 0.000 description 1
- WQKRRKYIDQHJPO-UHFFFAOYSA-N n-methyl-2-[5-methyl-2-[2-(1-methylpiperidin-4-yl)ethylamino]pyrimidin-4-yl]-1-benzothiophene-6-carboxamide Chemical compound S1C2=CC(C(=O)NC)=CC=C2C=C1C(C(=CN=1)C)=NC=1NCCC1CCN(C)CC1 WQKRRKYIDQHJPO-UHFFFAOYSA-N 0.000 description 1
- AHNHXHYLOGBUTC-UHFFFAOYSA-N n-methyl-2-[5-methyl-2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-1-benzothiophene-4-carboxamide Chemical compound C=1C=2C(C(=O)NC)=CC=CC=2SC=1C(C(=CN=1)C)=NC=1NCCCN1CCN(C)CC1 AHNHXHYLOGBUTC-UHFFFAOYSA-N 0.000 description 1
- IYKIHDRDNJDVHU-INIZCTEOSA-N n-methyl-2-[5-methyl-2-[3-[(2s)-2-methylpiperazin-1-yl]propylamino]pyrimidin-4-yl]-1-benzothiophene-4-carboxamide Chemical compound C=1C=2C(C(=O)NC)=CC=CC=2SC=1C(C(=CN=1)C)=NC=1NCCCN1CCNC[C@@H]1C IYKIHDRDNJDVHU-INIZCTEOSA-N 0.000 description 1
- IFSZEBQWBWOLKA-INIZCTEOSA-N n-methyl-2-[5-methyl-2-[3-[(3s)-3-methylpiperazin-1-yl]propylamino]pyrimidin-4-yl]-1-benzothiophene-4-carboxamide Chemical compound C=1C=2C(C(=O)NC)=CC=CC=2SC=1C(C(=CN=1)C)=NC=1NCCCN1CCN[C@@H](C)C1 IFSZEBQWBWOLKA-INIZCTEOSA-N 0.000 description 1
- GEMDSWZIFPIWFZ-UHFFFAOYSA-N n-methyl-3-[2-[2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-1-benzothiophen-6-yl]benzamide Chemical compound CNC(=O)C1=CC=CC(C=2C=C3SC(=CC3=CC=2)C=2N=C(NCCCN3CCN(C)CC3)N=CC=2)=C1 GEMDSWZIFPIWFZ-UHFFFAOYSA-N 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- MUJIDPITZJWBSW-UHFFFAOYSA-N palladium(2+) Chemical compound [Pd+2] MUJIDPITZJWBSW-UHFFFAOYSA-N 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 229940080469 phosphocellulose Drugs 0.000 description 1
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 1
- 125000005543 phthalimide group Chemical class 0.000 description 1
- RFIOZSIHFNEKFF-UHFFFAOYSA-N piperazine-1-carboxylic acid Chemical compound OC(=O)N1CCNCC1 RFIOZSIHFNEKFF-UHFFFAOYSA-N 0.000 description 1
- 239000003880 polar aprotic solvent Substances 0.000 description 1
- LZMJNVRJMFMYQS-UHFFFAOYSA-N poseltinib Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(OC=2C=C(NC(=O)C=C)C=CC=2)=C(OC=C2)C2=N1 LZMJNVRJMFMYQS-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- FYRHIOVKTDQVFC-UHFFFAOYSA-M potassium phthalimide Chemical compound [K+].C1=CC=C2C(=O)[N-]C(=O)C2=C1 FYRHIOVKTDQVFC-UHFFFAOYSA-M 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000009696 proliferative response Effects 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- DOYOPBSXEIZLRE-UHFFFAOYSA-N pyrrole-3-carboxylic acid Natural products OC(=O)C=1C=CNC=1 DOYOPBSXEIZLRE-UHFFFAOYSA-N 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000006485 reductive methylation reaction Methods 0.000 description 1
- 230000022983 regulation of cell cycle Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- RMBAVIFYHOYIFM-UHFFFAOYSA-M sodium methanethiolate Chemical compound [Na+].[S-]C RMBAVIFYHOYIFM-UHFFFAOYSA-M 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- GFYHSKONPJXCDE-UHFFFAOYSA-N sym-collidine Natural products CC1=CN=C(C)C(C)=C1 GFYHSKONPJXCDE-UHFFFAOYSA-N 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- SNLWYFMDXBEOGE-LLVKDONJSA-N tert-butyl (3r)-4-(3-aminopropyl)-3-methylpiperazine-1-carboxylate Chemical compound C[C@@H]1CN(C(=O)OC(C)(C)C)CCN1CCCN SNLWYFMDXBEOGE-LLVKDONJSA-N 0.000 description 1
- ZRYDCWWNCKKREA-UHFFFAOYSA-N tert-butyl 3-(3-methylsulfonyloxypropyl)piperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCCC(CCCOS(C)(=O)=O)C1 ZRYDCWWNCKKREA-UHFFFAOYSA-N 0.000 description 1
- IKEURFVSAUCQQW-UHFFFAOYSA-N tert-butyl 4-(2-cyano-1-methylsulfonyloxyethyl)-4-methylpiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(C)(C(CC#N)OS(C)(=O)=O)CC1 IKEURFVSAUCQQW-UHFFFAOYSA-N 0.000 description 1
- KGIVNBCHQVUGMM-UHFFFAOYSA-N tert-butyl 4-(3-amino-1-hydroxypropyl)-4-methylpiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(C)(C(O)CCN)CC1 KGIVNBCHQVUGMM-UHFFFAOYSA-N 0.000 description 1
- SQJTVQSZFVOIQV-UHFFFAOYSA-N tert-butyl 4-(3-bromopropyl)piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCN(CCCBr)CC1 SQJTVQSZFVOIQV-UHFFFAOYSA-N 0.000 description 1
- GPLDUALYAYSMEE-UHFFFAOYSA-N tert-butyl 4-methyl-4-(methylsulfonyloxymethyl)piperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(C)(COS(C)(=O)=O)CC1 GPLDUALYAYSMEE-UHFFFAOYSA-N 0.000 description 1
- BEYPLCFQKGMXOY-UHFFFAOYSA-N tert-butyl 5-(2-aminoethyl)-2,3,3a,4,6,6a-hexahydro-1h-pyrrolo[3,4-c]pyrrole-3-carboxylate Chemical compound C1N(CCN)CC2C(C(=O)OC(C)(C)C)NCC21 BEYPLCFQKGMXOY-UHFFFAOYSA-N 0.000 description 1
- LFKDJXLFVYVEFG-UHFFFAOYSA-N tert-butyl carbamate Chemical compound CC(C)(C)OC(N)=O LFKDJXLFVYVEFG-UHFFFAOYSA-N 0.000 description 1
- RKRXZHZDUUMIKY-UHFFFAOYSA-N tert-butyl n-[2-(2-chloro-5-methylpyrimidin-4-yl)-1-benzothiophen-6-yl]carbamate Chemical compound CC1=CN=C(Cl)N=C1C1=CC2=CC=C(NC(=O)OC(C)(C)C)C=C2S1 RKRXZHZDUUMIKY-UHFFFAOYSA-N 0.000 description 1
- MRORCVDHNJKPPY-UHFFFAOYSA-N tert-butyl n-[[2-(2-chloropyrimidin-4-yl)-1-benzothiophen-6-yl]methyl]carbamate Chemical compound S1C2=CC(CNC(=O)OC(C)(C)C)=CC=C2C=C1C1=CC=NC(Cl)=N1 MRORCVDHNJKPPY-UHFFFAOYSA-N 0.000 description 1
- SRJCQOUDPCYNIB-UHFFFAOYSA-N tert-butyl n-[[2-[2-[3-(4-methylpiperazin-1-yl)propylamino]pyrimidin-4-yl]-1-benzothiophen-6-yl]methyl]carbamate Chemical compound C1CN(C)CCN1CCCNC1=NC=CC(C=2SC3=CC(CNC(=O)OC(C)(C)C)=CC=C3C=2)=N1 SRJCQOUDPCYNIB-UHFFFAOYSA-N 0.000 description 1
- DKACXUFSLUYRFU-UHFFFAOYSA-N tert-butyl n-aminocarbamate Chemical compound CC(C)(C)OC(=O)NN DKACXUFSLUYRFU-UHFFFAOYSA-N 0.000 description 1
- YPPDPANYMIUZJG-UHFFFAOYSA-N tert-butyl thiophene-3-carboxylate Chemical compound CC(C)(C)OC(=O)C=1C=CSC=1 YPPDPANYMIUZJG-UHFFFAOYSA-N 0.000 description 1
- TWRVYXVQOJCHIF-UHFFFAOYSA-N tert-butyl-chloro-methylsilane Chemical compound C[SiH](Cl)C(C)(C)C TWRVYXVQOJCHIF-UHFFFAOYSA-N 0.000 description 1
- XBXCNNQPRYLIDE-UHFFFAOYSA-N tert-butylcarbamic acid Chemical class CC(C)(C)NC(O)=O XBXCNNQPRYLIDE-UHFFFAOYSA-N 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- IHIXIJGXTJIKRB-UHFFFAOYSA-N trisodium vanadate Chemical compound [Na+].[Na+].[Na+].[O-][V]([O-])([O-])=O IHIXIJGXTJIKRB-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229910001845 yogo sapphire Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73809705P | 2005-11-18 | 2005-11-18 | |
| US738097P | 2005-11-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2329085T3 true ES2329085T3 (es) | 2009-11-20 |
Family
ID=38345605
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES06850430T Active ES2329085T3 (es) | 2005-11-18 | 2006-11-15 | Derivados de (4-(benzo(b)tiofen-2-il)-pirimidin-2-il)-amina como inhibidores de ikk-beta para el tratamiento del cancer y de enfermedades inflamatorias. |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US7547691B2 (enExample) |
| EP (1) | EP1989200B1 (enExample) |
| JP (1) | JP2009516697A (enExample) |
| KR (1) | KR100990771B1 (enExample) |
| CN (1) | CN101309918B (enExample) |
| AR (1) | AR057911A1 (enExample) |
| AT (1) | ATE437873T1 (enExample) |
| AU (1) | AU2006337626B2 (enExample) |
| BR (1) | BRPI0618245A2 (enExample) |
| CA (1) | CA2629336A1 (enExample) |
| CR (1) | CR9947A (enExample) |
| DE (1) | DE602006008187D1 (enExample) |
| DK (1) | DK1989200T3 (enExample) |
| EA (1) | EA014426B1 (enExample) |
| EC (1) | ECSP088456A (enExample) |
| ES (1) | ES2329085T3 (enExample) |
| IL (1) | IL190489A0 (enExample) |
| MA (1) | MA30053B1 (enExample) |
| NO (1) | NO20082594L (enExample) |
| PE (1) | PE20070833A1 (enExample) |
| PL (1) | PL1989200T3 (enExample) |
| PT (1) | PT1989200E (enExample) |
| SI (1) | SI1989200T1 (enExample) |
| TN (1) | TNSN08227A1 (enExample) |
| TW (1) | TW200800201A (enExample) |
| WO (1) | WO2007092095A2 (enExample) |
| ZA (1) | ZA200803940B (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ME01143B (me) | 2006-03-31 | 2013-03-20 | Janssen Pharmaceutica Nv | BENZOIMIDAZOL-2-IL PIRIMIDINI l PIRAZINI KAO MODULATORI HISTAMINSKOG H4 RECEPTORA |
| US20080021217A1 (en) * | 2006-07-20 | 2008-01-24 | Allen Borchardt | Heterocyclic inhibitors of rho kinase |
| US8063212B2 (en) * | 2006-12-21 | 2011-11-22 | Eli Lilly And Company | Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer |
| CN101563342B (zh) * | 2006-12-21 | 2012-09-05 | 伊莱利利公司 | 用于治疗癌症的咪唑啉酮基氨基嘧啶化合物 |
| PE20090803A1 (es) | 2007-05-16 | 2009-07-11 | Lilly Co Eli | Compuestos triazolil aminopirimidin como inhibidores de plk1 |
| MX2009012228A (es) | 2007-05-16 | 2009-12-01 | Lilly Co Eli | Compuesto de triazolil aminopirimidina. |
| MX2011000080A (es) | 2008-06-30 | 2011-03-02 | Janssen Pharmaceutica Nv | Proceso para la preparacion de derivados de pirimidina sustituidos. |
| US9371311B2 (en) | 2008-06-30 | 2016-06-21 | Janssen Pharmaceutica Nv | Benzoimidazol-2-yl pyrimidine derivatives |
| KR101123178B1 (ko) * | 2009-04-09 | 2012-06-13 | (주)에스메디 | 2-아릴벤조싸이오펜 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 퇴행성 뇌질환의 진단 또는 치료용 약학적 조성물 |
| KR20120059558A (ko) | 2009-08-19 | 2012-06-08 | 암비트 바이오사이언시즈 코포레이션 | 바이아릴 화합물 및 이의 사용 방법 |
| MX2012012502A (es) | 2010-04-27 | 2013-01-18 | Hutchison Medipharma Ltd | Compuestos pirimidinil indol. |
| US20140194383A1 (en) | 2011-04-07 | 2014-07-10 | Cornell University | Monomers capable of dimerizing in an aqueous solution, and methods of using same |
| US9245773B2 (en) | 2011-09-02 | 2016-01-26 | Taiwan Semiconductor Manufacturing Company, Ltd. | Semiconductor device packaging methods and structures thereof |
| CN103159742B (zh) * | 2011-12-16 | 2015-08-12 | 北京韩美药品有限公司 | 5-氯嘧啶类化合物及其作为egfr酪氨酸激酶抑制剂的应用 |
| CA2864085C (en) | 2012-02-08 | 2021-11-23 | Sunovion Pharmaceuticals Inc. | Heteroaryl compounds and methods of use thereof |
| UY35464A (es) | 2013-03-15 | 2014-10-31 | Araxes Pharma Llc | Inhibidores covalentes de kras g12c. |
| TWI659021B (zh) | 2013-10-10 | 2019-05-11 | 亞瑞克西斯製藥公司 | Ｋｒａｓ ｇ１２ｃ之抑制劑 |
| CN105085434B (zh) * | 2014-05-09 | 2018-02-09 | 上海特化医药科技有限公司 | 硫乙拉嗪或其中间体的制备方法 |
| WO2017076888A1 (en) * | 2015-11-03 | 2017-05-11 | Janssen Pharmaceutica Nv | 2-[3-(1-methyl-piperidin-4-yl)-propylamino]-pyrimidine-5-carboxylic acids and amides and methods of making the same |
| WO2018023070A1 (en) | 2016-07-29 | 2018-02-01 | Sunovion Pharmaceuticals, Inc. | Compounds and compositions and uses thereof |
| MY199446A (en) | 2016-07-29 | 2023-10-28 | Sunovion Pharmaceuticals Inc | Compounds and compositions and uses thereof |
| US11279689B2 (en) | 2017-01-26 | 2022-03-22 | Araxes Pharma Llc | 1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1 yl)prop-2-en-1-one derivatives and similar compounds as KRAS G12C modulators for treating cancer |
| WO2018140512A1 (en) | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | Fused bicyclic benzoheteroaromatic compounds and methods of use thereof |
| WO2018140514A1 (en) | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | 1-(6-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl)azetidin-1-yl)prop-2-en-1-one derivatives and similar compounds as kras g12c inhibitors for the treatment of cancer |
| WO2018140599A1 (en) * | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | Benzothiophene and benzothiazole compounds and methods of use thereof |
| AU2018271990A1 (en) | 2017-05-25 | 2019-12-12 | Araxes Pharma Llc | Covalent inhibitors of KRAS |
| US11639346B2 (en) | 2017-05-25 | 2023-05-02 | Araxes Pharma Llc | Quinazoline derivatives as modulators of mutant KRAS, HRAS or NRAS |
| KR20200036008A (ko) | 2017-08-02 | 2020-04-06 | 선오비온 파마슈티컬스 인코포레이티드 | 이소크로만 화합물 및 이의 용도 |
| US12134620B2 (en) | 2018-08-01 | 2024-11-05 | Araxes Pharma Llc | Heterocyclic spiro compounds and methods of use thereof for the treatment of cancer |
| CN113784755B (zh) | 2019-03-14 | 2024-05-10 | 赛诺维信制药公司 | 异色满基化合物的盐及其结晶形式、制备方法、治疗用途和药物组合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989011279A1 (en) * | 1988-05-16 | 1989-11-30 | Georgia State University Foundation, Inc. | Nucleic acid interacting unfused heteropolycyclic compounds |
| GB0308466D0 (en) * | 2003-04-11 | 2003-05-21 | Novartis Ag | Organic compounds |
| CN101115749B (zh) * | 2004-12-17 | 2011-06-22 | 安姆根有限公司 | 氨基嘧啶化合物和使用方法 |
-
2006
- 2006-10-23 TW TW095139053A patent/TW200800201A/zh unknown
- 2006-11-15 WO PCT/US2006/060911 patent/WO2007092095A2/en not_active Ceased
- 2006-11-15 KR KR1020087011830A patent/KR100990771B1/ko not_active Expired - Fee Related
- 2006-11-15 EP EP06850430A patent/EP1989200B1/en active Active
- 2006-11-15 PT PT06850430T patent/PT1989200E/pt unknown
- 2006-11-15 DK DK06850430T patent/DK1989200T3/da active
- 2006-11-15 JP JP2008541463A patent/JP2009516697A/ja not_active Ceased
- 2006-11-15 PL PL06850430T patent/PL1989200T3/pl unknown
- 2006-11-15 SI SI200630446T patent/SI1989200T1/sl unknown
- 2006-11-15 DE DE602006008187T patent/DE602006008187D1/de active Active
- 2006-11-15 BR BRPI0618245-3A patent/BRPI0618245A2/pt not_active IP Right Cessation
- 2006-11-15 PE PE2006001456A patent/PE20070833A1/es not_active Application Discontinuation
- 2006-11-15 AT AT06850430T patent/ATE437873T1/de active
- 2006-11-15 EA EA200801362A patent/EA014426B1/ru not_active IP Right Cessation
- 2006-11-15 AU AU2006337626A patent/AU2006337626B2/en not_active Ceased
- 2006-11-15 CA CA002629336A patent/CA2629336A1/en not_active Abandoned
- 2006-11-15 CN CN2006800428126A patent/CN101309918B/zh not_active Expired - Fee Related
- 2006-11-15 ES ES06850430T patent/ES2329085T3/es active Active
- 2006-11-15 US US12/093,024 patent/US7547691B2/en not_active Expired - Fee Related
- 2006-11-17 AR ARP060105065A patent/AR057911A1/es unknown
-
2008
- 2008-03-27 IL IL190489A patent/IL190489A0/en unknown
- 2008-04-29 CR CR9947A patent/CR9947A/es not_active Application Discontinuation
- 2008-05-08 ZA ZA200803940A patent/ZA200803940B/xx unknown
- 2008-05-16 EC EC2008008456A patent/ECSP088456A/es unknown
- 2008-05-16 TN TNP2008000227A patent/TNSN08227A1/en unknown
- 2008-06-10 NO NO20082594A patent/NO20082594L/no not_active Application Discontinuation
- 2008-06-13 MA MA31035A patent/MA30053B1/fr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2329085T3 (es) | Derivados de (4-(benzo(b)tiofen-2-il)-pirimidin-2-il)-amina como inhibidores de ikk-beta para el tratamiento del cancer y de enfermedades inflamatorias. | |
| EP2044051B1 (en) | Pyridine and pyrazine derivatives as mnk kinase inhibitors | |
| ES2328042T3 (es) | Derivados de pirazol como unhibidores de los receptores tirosina cinasa. | |
| DK2552909T3 (en) | 4-aminopyrimidine derivatives and their use as adenosine A 2A receptor antagonists | |
| US8017611B2 (en) | Pyridine and pyrazine derivatives -083 | |
| US20090233928A1 (en) | Imidazolo-5-yl-2-anilo-pyrimidines as agents for the inhibition of cell proliferation | |
| US20030225097A1 (en) | Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by np y5 receptor | |
| AU2005286795A1 (en) | Chemical compounds | |
| BRPI0619823B1 (pt) | compostos que são inibidores de erk | |
| JP2009538351A (ja) | 細胞増殖阻害剤としての２−ヘテロシクロアミノ−４−イミダゾリルピリミジン | |
| BRPI0613452A2 (pt) | derivados de 2,4-dianilino pirimidinas, o respectivo preparo, a tìtulo de medicamentos, composições farmacêuticas e notadamente como inibidores de ikk | |
| CA2640398A1 (en) | 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them | |
| EP1358157A1 (en) | Carbazole derivatives and their use as neuropeptide y5 receptor ligands | |
| AU2007242594A1 (en) | Pyrimidine derivatives as PI3K inhibitors | |
| IL199019A (en) | History of acylaminopyrazole, processes for their preparation, and their use in drug production | |
| JP2006508050A (ja) | ゴナドトロピン放出ホルモンのアンタゴニストとしてのチエノピロール化合物 | |
| JP2006501232A (ja) | ゴナドトロピン放出ホルモン（ＧｎＲＨ）のアンタゴニストとしての６Ｈ−チエノ−２，３−ビピロール誘導体 | |
| JP2007523149A (ja) | ＧｎＲＨアンタゴニストとしてのチエノピロールの誘導体 | |
| JP2006501230A (ja) | Ｇｎｒｈアンタゴニストとして有用なインドリルアルキルアミノ−メチリデンカルバメート | |
| WO2004018459A1 (en) | Pyrazole derivatives as gnrh inhibitors | |
| AU2002217269A1 (en) | Carbazole derivatives and their use as neuropeptide Y5 receptor ligands |